drug distribution business plan

Sample Pharmaceutical Distribution Business Plan

Pharmaceutical wholesale distribution business plan sample.

The pharmaceutical marketing business is mainly concerned with the wholesaling of pharmaceuticals and medical products which are distributed to hospitals, specialist retailers, specialist medical practitioners, doctors, and retail pharmacies.

Starting up a pharmaceutical distribution business, I believe you must have acquainted yourself with all that is necessary towards starting up this business and are set to carve out your own business plan.

This article will provide you with a very simple and practical pharmaceutical distribution business plan sample which will guide you in writing your own.

Here is a sample business plan for starting a pharma distribution business.

BUSINESS NAME:  Henry Olson Pharmaceutical Distribution Company.

• Executive Summary

Our Products and Services

Vision Statement

Mission Statement

Business Structure

• Market Analysis

Sales and Marketing Strategy

• Financial Plan

Sales Forecast

  Executive Summary

Henry Olson Pharmaceutical Distribution Company has been fully registered and has duly fulfilled all of the legal requirements necessary towards starting up in New York, United States. The business will be focused on offering a number of quality and professional products and services to customers.

Henry Olson Pharmaceutical Distribution Company will be owned by Henry Olson, who will also be the CEO of the business. Henry Olson has thus resolved to contribute a total of $700,000 towards the startup capital. The remainder, however, has been agreed to be sourced from the owner’s friends and family, as well as his bank.

Henry Olson Pharmaceutical Distribution Company will be a pharmaceutical distribution company that will be situated in New York, United States. It will be focused on delivering very quality and professional products and services to customers of all sorts both in New York City and in the whole of the United States.

The following products and services will be offered by Henry Olson Pharmaceutical Distribution Company to its customers:

• Wholesaling of both generic and branded drugs to local pharmacies, chain pharmacies, internet pharmacies, etc.
• Advisory Services
• Wholesaling of medical related equipment

Our vision in the pharmaceutical industry is to nurture a thriving pharmaceutical distribution company that will become the number one choice for customers in New York, and all major cities in the United States. We want to make sure we are counted among the top 5 pharmaceutical distribution companies in the whole of the United States.

We have a mission, which is to raise a pharmaceutical distribution company that will be a standard for all pharmaceutical distribution companies in New York, and surrounding cities in the United States. Also, we want to build a pharmaceutical distribution company that will be trust-worthy to our customers.

We are very focused on building a pharmaceutical distribution company that will be able to compete favorably with competitors in the industry. For us to accomplish this goal, we must build a very strong business structure. This is why we will be focused on recruiting only employees that are qualified, experienced, and ready to work with us to achieve our business goals.

Here are the positions that will be occupied by candidates who meet our criteria:

• Chief Executive Officer
• Human Resources Manager
• Inventory and Purchasing  manager
• Sales and Marketing Executives
• Customer Service Executive
• Truck Drivers
• Accountants / Cashiers

Market Analysis Target Market

Here is a list of the groups making up our target market:

• Specialist Retailers
• Internet Pharmaceutical Companies
• Residents in our location
• Retail Pharmacy stores
• Non-governmental Organizations
• Health Clinics and Facilities

Here is how we have intended to go about promoting our pharmaceutical distribution company:

• We will begin with using fliers and our business brochures to introduce our pharmaceutical distribution business to prospective customers.
• We will make sure we utilize word of the mouth in promoting our business.
• We will not hesitate to list our pharmaceutical distribution company on yellow page ads.
• We will use local media such as Radio and TV stations, local newspapers and magazines, etc to ensure we advertise our business to prospective customers.
• We will take our business to the social media world of Facebook, Twitter, and Instagram

Financial Plan Source of Startup Capital

Starting up our pharmaceutical distribution company, we have realized we will require a total of $1,200,000 to fully startup our pharmaceutical distribution business in New York, United States.

This capital will, however, be obtained from the owner, from his friends and family, as well as from his bank. The owner has resolved to provide $700,000 towards the contribution of the startup capital. The remainder will be sourced from the owner’s friends and family, and from his bank.

First Fiscal Year $1,700,000 Second Fiscal Year $3,500,000 Third Fiscal Year $7,000,000

Above is a pharmaceutical distribution business plan sample with the business name, ‘Henry Olson Pharmaceutical Distribution Company’. The business will be located in New York, United States; and it will be owned by Henry Olson.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Crafting a Pharmaceutical Distribution Business Plan

• Pharmaceutical Industry

In the dynamic landscape of the pharmaceutical industry , a well-thought-out business plan is the foundation for success in the distribution sector. Whether entering the field or looking to revamp your existing operations, a pharmaceutical distribution business plan is essential for outlining your goals, strategies, and the path to sustainable growth. This guide delves into the key components that should be included in a pharmaceutical distribution business plan.

1. Executive Summary: Setting the Stage

The executive summary is a concise yet impactful overview that is the gateway to your pharmaceutical distribution business plan. In this section, you aim to capture readers’ attention, including potential investors, partners, and stakeholders, by presenting a compelling snapshot of your business.

Mission, Vision, and Core Values

Begin the executive summary by articulating your company’s mission, vision, and core values. Clearly define the purpose of your pharmaceutical distribution business, the long-term aspirations encapsulated in your vision, and the guiding principles that underpin your operations. This sets the tone for the entire business plan, providing a foundation that aligns with the broader goals of the healthcare industry.

Key Objectives

Outline the primary objectives that your pharmaceutical distribution business aims to achieve. Whether it’s expanding market reach, optimizing supply chain efficiency, or introducing innovative distribution solutions, clearly articulate the specific goals that define your business trajectory.

Target Markets

Identify and describe your target markets. Specify the geographical regions you operate in, the demographics of your intended customer base, and any niche markets you plan to serve. This provides readers with a clear understanding of the scope and potential of your pharmaceutical distribution business.

Unique Value Proposition (UVP)

Highlight the unique value proposition that distinguishes your pharmaceutical distribution business from competitors. Communicate the benefits you bring to clients, emphasizing what sets you apart regarding service quality, innovation, or other factors contributing to your competitive edge.

2. Company Description: Defining Your Identity

The Company Description section of your pharmaceutical distribution business plan provides a detailed exploration of the fundamental aspects that define your company’s identity. This section offers readers an in-depth understanding of your business’s history, mission, values, product offerings, geographical reach, and strategic collaborations.

Company History

Commence the Company Description by providing a historical overview of your pharmaceutical distribution business. Share key milestones, significant achievements, and pivotal moments that have shaped the trajectory of your company. This offers insight into your business’s evolution and establishes a narrative that connects with readers.

Mission and Values

Articulate your company’s mission and values, delving into the core principles that guide your operations. Communicate the purpose of your pharmaceutical distribution business and the ethical framework that underlies your decision-making processes.

Product Offerings

Provide a comprehensive overview of your distribution business’s pharmaceutical products and services. Detail the range of products you distribute, including prescription medications, over-the-counter drugs, vaccines, and any specialized healthcare products. Highlight any unique features or attributes that set your product portfolio apart.

Geographical Reach

Specify the geographical areas your pharmaceutical distribution business serves. Whether you operate locally, nationally, or internationally, clarify the regions you cover. Discuss any expansion plans or strategic considerations related to your geographical reach.

Key Partnerships and Collaborations

Highlight any key partnerships, collaborations, or alliances that contribute to the success of your pharmaceutical distribution business. This may involve collaborations with pharmaceutical manufacturers, technology providers, or other entities that enhance the efficiency and effectiveness of your operations.

3. Market Analysis: Understanding the Landscape

The Market Analysis section of your pharmaceutical distribution business plan is a critical component that thoroughly examines the external factors shaping the industry. This in-depth analysis aids in identifying opportunities, anticipating challenges, and strategically positioning your business within the pharmaceutical distribution landscape.

Industry Overview

Initiate the Market Analysis by presenting a comprehensive overview of the pharmaceutical distribution industry. Discuss the industry’s current state, including its size, growth trends, and key drivers. This section sets the stage for a nuanced understanding of the broader landscape in which your business operates.

Market Trends

Examine the prevailing trends within the pharmaceutical distribution industry. This involves an analysis of emerging patterns, technological advancements, and shifts in consumer behavior. Identifying and adapting to these trends is crucial for staying ahead of the curve and aligning your business strategies with industry dynamics.

Competitor Landscape

Conduct a thorough analysis of your competitors within the pharmaceutical distribution space. Identify key players, their market share, distribution strategies, and areas of specialization. This assessment helps you understand the competitive dynamics and formulate strategies to differentiate your business.

Regulatory Environment

Explore the regulatory landscape governing pharmaceutical distribution. Highlight any recent or anticipated changes in regulations that may impact your business. Understanding and complying with regulatory requirements is vital for ensuring the legality and sustainability of your operations.

Target Customer Base

Define your target customer base within the pharmaceutical distribution market. This involves identifying the types of healthcare providers, pharmacies, or other entities you aim to serve. Understanding your target customers’ needs, preferences, and expectations is crucial for tailoring your distribution strategies.

SWOT Analysis

Conduct a SWOT analysis (Strengths, Weaknesses, Opportunities, Threats) to assess the internal and external factors influencing your pharmaceutical distribution business. This analysis provides a holistic perspective, helping you capitalize on strengths, address weaknesses, seize opportunities, and mitigate potential threats.

4. Organization and Management: Building a Strong Foundation

The Organization and Management section of your pharmaceutical distribution business plan is a crucial segment that provides an in-depth exploration of the structure and leadership of your company. This section offers readers insights into the key players steering your pharmaceutical distribution operations, emphasizing their experience, expertise, and contributions to the business’s overall success.

Organizational Structure

Commence this section by outlining the organizational structure of your pharmaceutical distribution business. Clearly define your company’s hierarchy, departmental divisions, and reporting lines. This offers readers a visual representation of how your business is organized and how various components collaborate to achieve common goals.

Key Roles and Responsibilities

Specify the key roles and responsibilities within your pharmaceutical distribution business. This involves detailing the functions of each department and the specific responsibilities of key positions. Clarifying roles helps establish accountability and ensures that every aspect of your distribution operations is well-defined.

Management Team

Introduce your management team, emphasizing their professional backgrounds, qualifications, and relevant experience. Highlight key executives and their respective roles in steering the company toward success. This is an opportunity to showcase the strength and diversity of your leadership, instilling confidence in readers about the capabilities of your management team.

Biographies of Key Executives

Provide detailed biographies of key executives, highlighting their professional achievements, educational backgrounds, and specific contributions to the pharmaceutical distribution industry. This personalized touch adds credibility to your management team, allowing readers to connect with the individuals driving your business forward.

Experience and Expertise

Emphasize the collective experience and expertise of your management team. Discuss any industry-specific knowledge, certifications, or accolades that demonstrate the competency of your leadership. This section is an opportunity to reassure readers that your team possesses the necessary skills to navigate the complexities of pharmaceutical distribution.

5. Products and Services: Showcasing Your Portfolio

The Products and Services section of your pharmaceutical distribution business plan is a pivotal segment that offers a comprehensive view of the range of pharmaceutical products and services your distribution business provides. This section serves as a platform to highlight the unique aspects of your portfolio, emphasizing how your offerings align with market demand and contribute to emerging healthcare trends.

Overview of Pharmaceutical Products

Initiate this section by providing a detailed overview of the pharmaceutical products your distribution business offers. This includes prescription drugs, over-the-counter medications, vaccines, medical devices, and other healthcare products within your portfolio. Clearly define the scope of your product range to give readers a holistic understanding of your offerings.

Specialization Areas

Highlight any specific areas of specialization within your product portfolio. This could involve focusing on particular therapeutic categories, specialized medications, or niche healthcare segments. Emphasizing your specialization areas showcases expertise and allows you to position your distribution business as a go-to source for specific healthcare needs.

Exclusive Partnerships

Discuss any exclusive partnerships your distribution business has established with pharmaceutical manufacturers. Exclusive partnerships can contribute to the uniqueness of your product portfolio, giving you a competitive edge. Highlighting these collaborations demonstrates your ability to secure premium products and reinforces your credibility within the industry.

Unique Selling Points (USPs)

Identify and emphasize the unique selling points that distinguish your pharmaceutical products and services. This could include features such as superior quality, innovative formulations, special packaging, or any other factors that set your offerings apart from competitors. Clearly articulating your USPs helps create a compelling value proposition for your customers.

Alignment with Market Demand

Demonstrate how your product portfolio aligns with current market demand. This involves an analysis of industry trends, consumer preferences, and healthcare needs. Illustrate how your distribution business proactively responds to market dynamics, ensuring that your offerings address the evolving requirements of healthcare providers and end consumers.

Contribution to Emerging Healthcare Trends

Discuss how your products and services contribute to or align with emerging healthcare trends. This could involve advancements in personalized medicine, digital health solutions, or any other transformative trends shaping the pharmaceutical industry. Positioning your distribution business as a contributor to healthcare innovation enhances your industry standing.

6. Marketing and Sales Strategy: Reaching Your Audience

The Marketing and Sales Strategy section of your pharmaceutical distribution business plan is a critical component that outlines the methodologies you’ll employ to promote and sell your products and services effectively. This section serves as a roadmap, defining your target audience, elucidating marketing strategies, and detailing sales tactics to secure and retain clients.

Target Audience Definition

Begin by clearly defining your target audience. Identify the specific demographic, geographic, and psychographic characteristics of the individuals and organizations you aim to reach. Understanding your target audience is fundamental to tailoring your marketing and sales approaches to meet their needs effectively.

Marketing Strategies

Elaborate on the marketing strategies you’ll employ to reach your target audience. This may encompass digital marketing, traditional advertising, content marketing, and participation in industry events. Detail how each strategy contributes to brand visibility, lead generation, and engagement with potential clients.

Digital Marketing Approach

If applicable, provide details about your digital marketing approach. This could involve strategies for online visibility, content creation, social media engagement, and email marketing. Articulate how your digital presence will be leveraged to communicate your brand message and attract potential clients.

Traditional Advertising Channels

Discuss your approach to traditional advertising channels like print media, television, or radio. Clarify how these channels complement your overall marketing strategy and contribute to brand recognition among your target audience.

Partnerships with Healthcare Providers

Detail any partnerships or collaborations with healthcare providers contributing to your marketing strategy. These partnerships can enhance credibility and create avenues for direct engagement with potential clients.

Sales Tactics

Shift the focus to your sales tactics, outlining how to secure and retain clients. Discuss your approach to lead generation, client acquisition, and strategies for building long-term customer relationships.

Client Retention Strategies

Highlight strategies for client retention. This may involve after-sales support, loyalty programs, and ongoing communication to ensure customer satisfaction and foster long-term relationships.

7. Funding Request: Securing Resources

The Funding Request section of your pharmaceutical distribution business plan is a crucial segment where you clearly articulate your financial requirements should you seek external funding. This section serves as a detailed proposal, specifying the amount needed, the purpose behind the funding, and how the investment will be utilized to propel your pharmaceutical distribution business forward.

Amount Required

Start by explicitly stating the amount of funding you are seeking. This figure should be based on thoroughly assessing your business needs, considering expansion plans, operational requirements, technology investments, and marketing initiatives.

Purpose of the Funding

Clearly outline the purpose behind the funding request. Specify how the funds will be utilized and the key areas of your pharmaceutical distribution business that will benefit from the investment. This provides transparency and demonstrates a thoughtful consideration of your business needs.

Expected Return on Investment (ROI)

Discuss the expected return on investment that the funding is anticipated to generate. Provide a realistic projection of how the infusion of capital will contribute to the growth and profitability of your pharmaceutical distribution business over a defined period.

Utilization Breakdown

Offer a comprehensive breakdown of how the funds will be utilized. This involves providing a detailed list of expenses, investments, and allocations to different aspects of your business. This breakdown enhances transparency and instills confidence in potential investors or lenders.

Financial Projections

Support your funding request with financial projections that illustrate the anticipated impact of the investment on your business’s financial performance. Include projections for revenue growth, profit margins, and other key financial metrics over the period covered by the funding.

Risk Mitigation Strategies

Acknowledge potential risks associated with using funds and present strategies for mitigating these risks. This demonstrates foresight and a proactive approach to addressing challenges that may arise while implementing your business plan.

8. Financial Projections: Painting the Financial Landscape

The Financial Projections section of your pharmaceutical distribution business plan is a critical component that paints a comprehensive picture of your company’s anticipated financial performance. This section gives potential investors or lenders detailed insights into your revenue streams, expected expenses, profit margins, and overall financial health. Realistic, data-backed financial projections are crucial for instilling confidence and demonstrating the viability and profitability of your pharmaceutical distribution business.

Income Statements

Present detailed income statements forecasting your revenue streams and expenses over a defined period. Clearly outline your sources of revenue, including product sales, distribution services, or any other income-generating activities. Provide a breakdown of direct costs, operating expenses, and taxes to show your company’s profitability clearly.

Balance Sheets

Include balance sheets that showcase your company’s financial position at specific times. Highlight your assets, liabilities, and shareholders’ equity to provide a comprehensive overview of your financial stability and the resources available for your pharmaceutical distribution business.

Cash Flow Statements

Present detailed cash flow statements that illustrate the inflow and outflow of cash within your pharmaceutical distribution business. This includes operating activities, investing activities, and financing activities. Positive cash flow indicates your ability to meet financial obligations and reinvest in business growth.

Revenue Streams and Profit Margins

Provide a breakdown of your various revenue streams, emphasizing the diversity and stability of your income sources—detail profit margins for each revenue stream to showcase the financial viability of your pharmaceutical distribution business.

Expense Projections

Anticipate and detail your expected expenses, including operational costs, marketing expenditures, technology investments, and other relevant costs. A thorough breakdown of expenses demonstrates your understanding of the financial intricacies of your pharmaceutical distribution business.

Assumptions and Methodology

Clearly outline the assumptions and methodology underlying your financial projections. This is essential for transparency and helps potential investors or lenders understand the basis on which your projections have been formulated.

Sensitivity Analysis

Conduct sensitivity analysis to assess how changes in key variables may impact your financial projections. This demonstrates a proactive approach to risk management and provides insight into the robustness of your financial forecasts.

9. Risk Analysis: Identifying and Mitigating Challenges

The Risk Analysis section of your pharmaceutical distribution business plan is a crucial component that aims to foresee potential challenges and uncertainties your business may encounter. By acknowledging these risks and presenting well-thought-out mitigation strategies, you demonstrate a proactive approach to challenges, instilling confidence in potential investors or lenders regarding your ability to navigate uncertainties and ensure business continuity.

Regulatory Risks

Identify potential regulatory risks that may impact your pharmaceutical distribution business. Changes in pharmaceutical regulations, licensing requirements, or compliance standards can significantly influence operations. Clearly outline how your business plans to stay abreast of regulatory changes and adapt to evolving legal landscapes.

Supply Chain Disruptions

Anticipate challenges related to supply chain disruptions, including issues with product availability, transportation delays, or disruptions in manufacturing. Develop strategies to ensure a resilient supply chain, such as diversifying suppliers, implementing advanced inventory management systems, and fostering strong relationships with key suppliers.

Market Dynamics and Competition

Evaluate potential risks arising from changes in market dynamics or increased competition. Shifts in consumer preferences, entry of new competitors, or fluctuations in market demand can impact your business. Demonstrate a thorough understanding of market trends and articulate strategies to maintain a competitive edge.

Technological Advancements

Acknowledge risks related to technological advancements and the need for constant innovation. Failure to adapt to emerging technologies or changes in digital platforms can impact operational efficiency. Present strategies for incorporating new technologies and staying at the forefront of industry advancements.

Economic Conditions

Consider risks associated with economic fluctuations, currency exchange rates, or financial downturns. Economic uncertainties can impact consumer spending and overall market conditions. Showcase your understanding of economic factors and outline strategies to mitigate potential financial risks.

Cybersecurity and Data Privacy

Acknowledge the increasing importance of cybersecurity and data privacy in the digital age. Risks related to data breaches or cyber-attacks can have severe consequences. Present comprehensive cybersecurity measures and data protection protocols to safeguard sensitive information.

10. Implementation Plan: Turning Plans into Action

The Implementation Plan section of your pharmaceutical distribution business plan bridges strategic vision and tangible actions. It outlines the steps, timelines, and responsibilities required to bring your business strategy to life. This section is crucial for demonstrating the practicality and feasibility of your plans, providing stakeholders with a clear roadmap for the execution of key initiatives.

Strategic Milestones

Outline the major milestones that mark the implementation of your pharmaceutical distribution business plan. These milestones may include the expansion of distribution networks, the introduction of new product lines, the launch of marketing campaigns, or the integration of advanced technologies. Clearly define these objectives to give a comprehensive overview of your business trajectory.

Timeline and Phases

Develop a detailed timeline that outlines each milestone’s specific phases and durations. Break down the implementation process into manageable phases, providing a realistic overview of when each objective will be achieved. This timeline serves as a visual representation of the sequential progression of your business plan.

Responsibilities and Roles

Clearly define the responsibilities and roles of each team member involved in the implementation process. This section emphasizes the importance of a collaborative and coordinated effort. Highlight the specific skills and expertise each team member brings to the table, showcasing how their contributions align with the successful execution of the business plan.

Performance Metrics and Monitoring

Establish clear performance metrics for each milestone to assess the effectiveness of your implementation efforts. Define key performance indicators (KPIs) that align with your business objectives. Additionally, outline a monitoring and evaluation process to regularly assess progress, identify challenges, and make necessary adjustments to stay on course.

Contingency Plans

Anticipate potential challenges or deviations from the planned implementation and develop contingency plans. Addressing unforeseen circumstances with predefined alternative strategies demonstrates your readiness to adapt and ensures that your business plan remains resilient amid uncertainties.

11. Monitoring and Evaluation: Assessing Progress

The Monitoring and Evaluation section of your pharmaceutical distribution business plan is essential for gauging the success of your strategies, identifying areas for improvement, and ensuring ongoing adaptability in the dynamic business landscape. It involves establishing key performance indicators (KPIs), defining robust monitoring processes, and outlining an evaluation framework that aligns with your business objectives.

Key Performance Indicators (KPIs)

Identify and define key performance indicators that directly align with your pharmaceutical distribution business objectives. These indicators serve as quantifiable metrics to measure the success of your operations. KPIs provide insights into critical areas such as sales performance, customer satisfaction, supply chain efficiency, and market penetration.

Monitoring Processes

Detail the processes and tools you will employ to monitor ongoing activities and performance against the established KPIs. Whether through advanced analytics software, regular team meetings, or real-time dashboards, a well-defined monitoring process enables continuous visibility into the various facets of your pharmaceutical distribution business.

Regular Review Meetings

Schedule regular review meetings to assess the progress of your pharmaceutical distribution business. These meetings are opportunities to discuss performance metrics, share insights, and collectively address any challenges that may arise. The collaborative nature of these sessions fosters a proactive approach to problem-solving and continuous improvement.

Adaptive Strategies

Highlight your commitment to adaptability by emphasizing how you will adjust strategies based on the insights gathered through monitoring processes and review meetings. The ability to swiftly adapt to changing market conditions, consumer preferences, or operational challenges is crucial for long-term success in the pharmaceutical distribution industry.

Continuous Improvement Initiatives

Demonstrate your commitment to continuous improvement by outlining specific initiatives or actions that will be taken based on the findings of your monitoring and evaluation processes. Whether it’s refining operational workflows, enhancing customer service protocols, or optimizing supply chain logistics, continuous improvement ensures sustained growth and competitiveness.

12. Appendices: Supporting Documentation

The Appendices section of your pharmaceutical distribution business plan serves as a repository for supplementary materials that provide depth and credibility to the assertions and plans outlined in the document’s main body. While the core of the business plan remains concise and focused, the appendices offer an opportunity to include detailed documentation that enhances the understanding and confidence of stakeholders, whether they be investors, partners, or regulatory authorities.

Resumes of Key Personnel

Include detailed resumes of key personnel involved in the leadership and management of your pharmaceutical distribution business. Resumes should highlight relevant experience, qualifications, and achievements that position your team as capable and well-equipped to execute the outlined business strategies.

Market Research Data

If your market analysis in the main body of the business plan includes summarized data, the appendices offer an opportunity to include more extensive market research materials. This could include detailed reports, surveys, or other relevant data supporting your understanding of market trends, customer behavior, and competitive landscapes.

Legal Documents

Include any legal documents that are relevant to the operation of your pharmaceutical distribution business. This may encompass licensing agreements, permits, contracts, or any other legal documentation that assures stakeholders of your compliance with regulatory requirements and industry standards.

Financial Information

While the main body of the business plan includes financial projections, the appendices can house additional financial information for those stakeholders who seek more detailed insights. This could include historical financial statements, detailed breakdowns of expenses, or any other financial documentation supporting your projections’ credibility.

Supporting Visuals

If visuals such as charts, graphs, or images contribute to a better understanding of your business plan, consider placing them in the appendices. While the main body should remain focused, the appendices can accommodate supplementary visuals that enhance clarity and illustrate key points.

Conclusion: Guiding Your Path to Success

Crafting a pharmaceutical distribution business plan is a strategic exercise that requires careful consideration of various factors influencing the industry. A well-articulated plan serves as a roadmap for your business and demonstrates your commitment to success, instilling confidence in potential investors, partners, and stakeholders. Regularly revisit and update your business plan to adapt to evolving market dynamics, ensuring that your pharmaceutical distribution business remains agile, competitive, and positioned for sustained growth in the ever-evolving healthcare landscape.

Related Content

Challenges Facing Medical Sales Reps

Cleaning Validation Training

Building a Strong Network in the Pharmaceutical Industry

Starting A Pharmaceutical Wholesale Business: A Step-by-Step Guide

Table of Contents

The pharmaceutical wholesale business is a vital component of the healthcare industry, providing critical support to pharmacies and other healthcare providers. Starting a pharmaceutical wholesale business can be a rewarding and profitable venture for entrepreneurs with a passion for the industry and a strong understanding of the supply chain. However, it can also be a complex and challenging process, requiring extensive research, planning, and preparation.

This article aims to provide a comprehensive guide for starting a pharmaceutical wholesale business, covering every step of the process from market research to marketing and advertising. By following the steps outlined in this guide, aspiring entrepreneurs can increase their chances of success and build a thriving business in this exciting and dynamic industry.

Also Read: What is Pharmaceutical wholesale and how does it work?

Market Research

Market research is a critical first step in starting any new business venture, and the pharmaceutical wholesale industry is no exception. Conducting thorough market research will help entrepreneurs understand the size and growth potential of the market, as well as identify key players, trends, and challenges in the industry. Some important areas to research include:

• Demographic and geographic trends: Understanding the demographics and geography of your target market can help you identify potential customers and their needs.
• Market size and growth: Determining the size and growth rate of the pharmaceutical wholesale market can help you gauge the potential for success in this industry.
• Competition: Identifying key players in the pharmaceutical wholesale industry, as well as their strengths and weaknesses, can help you determine how to differentiate your business and compete effectively.
• Industry trends and regulations: Understanding current and emerging trends in the industry, as well as relevant regulations and standards, is critical to staying ahead of the competition and avoiding costly mistakes.

By conducting thorough market research, entrepreneurs can gain a better understanding of the industry and develop a strategic plan that maximizes their chances of success.

Business planning

After conducting market research, the next step in starting a pharmaceutical wholesale business is to create a comprehensive business plan. This plan should outline your business goals, strategies, and expected outcomes. Key elements of a business plan for a pharmaceutical wholesale business might include:

Executive Summary: A brief overview of the purpose and content of the business plan.

Company Description: An overview of your business, including its history, products and services, management structure, and ownership.

Market Analysis: A detailed analysis of the market, including market size, growth rate, and demographic trends.

Marketing and Sales Plan: A description of your marketing and sales strategies, including target customer segments, pricing strategies, and distribution channels.

Operations Plan: A description of the day-to-day operations of your business, including the management structure, processes, and systems.

Financial Plan: A detailed financial plan that includes projections for revenue, expenses, and profits.

Appendices: Additional materials, such as resumes of key personnel, industry research, and market data.

Creating a comprehensive business plan will help you focus your resources and efforts on the most critical aspects of your business. It can also serve as a roadmap for growth and help you secure funding from investors or lenders.

Also Read: 

• How to write a Pharmacy Start-up business plan  
• How to write Pharmacy internal business plan

Legal and regulatory requirements

Before starting a pharmaceutical wholesale business, it is important to understand the legal and regulatory requirements you will need to comply with. These requirements may include:

Business Licensing: You will likely need to obtain a business license to operate as a pharmaceutical wholesaler. This may include submitting an application, paying a fee, and passing a background check.

Wholesale Drug Licensing: You will also need to obtain a wholesale drug license from the regulatory body that oversees pharmaceuticals in your jurisdiction. This may require you to meet certain criteria, such as having a physical location, having a certain level of liability insurance, and passing a background check.

Drug Handling Requirements: You will need to comply with regulations regarding the handling and storage of drugs, including requirements for temperature control, security, and record-keeping.

Drug Labeling Requirements: You will need to ensure that all drugs you sell are properly labeled and meet regulatory requirements for product labeling, including information about the drug’s name, active ingredients, and dosage.

Tax Requirements: You will need to comply with federal, state, and local tax requirements, including registering for tax identification numbers, collecting and remitting sales tax, and filing tax returns.

By understanding the legal and regulatory requirements for your jurisdiction, you can ensure that you are in compliance with all rules and regulations and avoid potential penalties or legal issues down the road.

Starting a pharmaceutical wholesale business can be a significant investment, and securing adequate financing is crucial to its success. There are various options for financing a pharmaceutical wholesale business, including traditional loans, angel investors, venture capital, crowdfunding, and more. The best financing option for your business will depend on your specific needs and circumstances. In this section, we’ll explore different financing options and provide tips for securing funding for your pharmaceutical wholesale business.

• Traditional Loans: Traditional business loans from banks and other financial institutions are a common way to finance a new business. These loans typically require a strong credit score and a solid business plan, and they may also require collateral. Before applying for a loan, make sure to research different lenders and compare interest rates and repayment terms.
• Angel Investors: Angel investors are high-net-worth individuals who provide funding to start-ups in exchange for equity. They may be interested in your business if they believe it has high growth potential. To attract angel investors, you’ll need to have a compelling business plan and a clear understanding of your target market.
• Venture Capital: Venture capital firms provide funding to start-ups with high growth potential. They typically take an equity stake in the business and provide additional support, including mentorship and connections. To secure venture capital, you’ll need to have a strong business plan and a clear understanding of your target market.
• Crowdfunding: Crowdfunding involves raising funds from a large number of people through platforms like Kickstarter and Indiegogo. This option is best for businesses that have a strong online presence and a large network of supporters. To be successful with crowdfunding, you’ll need to create a compelling campaign that clearly explains your business and the benefits of supporting it.
• Government Grants and Tax Incentives: Many governments offer grants and tax incentives to support the growth of small businesses. Research the options available in your area to see if you may be eligible for any funding or tax breaks.
• Creating a Strong Business Plan: Having a well-researched and well-written business plan is key to securing funding for your pharmaceutical wholesale business. A business plan should include a clear description of your target market, a detailed market analysis, a marketing plan, and a financial plan that includes projections for revenue, expenses, and profits.

In conclusion, there are many options for financing a pharmaceutical wholesale business. The best option for you will depend on your specific needs and circumstances. By researching the available options, creating a strong business plan, and seeking support from experienced investors and mentors, you can secure the funding you need to start and grow your business.

Building a team

Building a Team for Pharmaceutical Wholesale Business:

• Identifying key roles in the business operations such as sales, marketing, logistics, and customer service.
• Hiring employees with relevant experience in the pharmaceutical industry and wholesale operations.
• Creating job descriptions that highlight the specific skills and qualifications required for each role.
• Utilizing online job boards, professional networks, and industry associations to reach a wide pool of potential candidates.
• Conducting in-depth interviews and reference checks to determine the best fit for each role.
• Providing comprehensive training and support for new hires to ensure they have the skills and knowledge needed to succeed in their role.
• Building a team-oriented and collaborative culture that values continuous learning and professional growth.
• Regularly reviewing and adjusting staffing levels based on changes in business needs and market conditions.

Operations and logistics

• Developing a logistics plan for receiving, storing and shipping drugs
• Setting up a warehouse for proper storage and handling of drugs
• Implementing processes for efficient order fulfillment
• Managing inventory and maintaining stock levels
• Building strong relationships with suppliers and partners in the supply chain
• Ensuring compliance with relevant regulations, including those related to handling and transportation of drugs.
• Incorporating technology, such as EDI and electronic prescribing, to streamline operations
• Training employees on proper storage, handling and transportation of drugs
• Continuously monitoring and improving logistics processes to ensure cost-effectiveness and efficiency.

Marketing and advertising

Promoting your wholesale pharmacy business: 

• Developing a marketing strategy 
• Establishing partnerships with healthcare providers and pharmaceutical manufacturers 
• Developing a robust online presence through websites, social media, and email marketing 
• Advertising through relevant trade publications and events 
• Building a referral network through existing customers and partners.

Adopting technology to enhance your wholesale pharmacy business: 

• Utilizing Electronic Data Interchange (EDI) to automate and streamline supply chain processes.
• Using inventory management software to monitor and manage drug stock levels.
• Implementing an e-prescribing system to improve the accuracy and speed of prescription orders. 
• Investing in barcode scanning and labeling technology to ensure accurate and efficient product identification and tracking.
• Exploring opportunities for automation to reduce operational costs and improve efficiency.

Tips and best practices

• Conduct Thorough Market Research: Before starting a pharmaceutical wholesale business, it is important to understand the market demand and competition. Conducting thorough market research will help you identify the target market, potential customers, and competition.
• Develop a Comprehensive Business Plan: A well-structured business plan will help you stay organized and on track as you start and grow your business. Your plan should include your business model, target market, financial projections, and marketing strategy.
• Stay Abreast of Legal and Regulatory Requirements: The pharmaceutical industry is highly regulated, and it is important to stay informed of the legal and regulatory requirements that apply to your business. This includes obtaining the necessary licenses, certifications, and permits, as well as complying with relevant laws and regulations.
• Secure Adequate Financing: Starting a pharmaceutical wholesale business can be expensive, and securing adequate financing is critical to your success. Consider various financing options, such as loans, grants, and investments, to ensure that you have the funds you need to start and grow your business.
• Build a Strong Team: Building a strong team of employees and contractors is key to the success of your business. Hire individuals who have the skills, experience, and passion for the pharmaceutical industry, and invest in training and development programs to keep them up-to-date with industry developments.
• Optimize Operations and Logistics: Streamlining your operations and logistics will help you reduce costs, increase efficiency, and improve the quality of your products and services. Consider investing in technology and automation to help you manage your operations and logistics more effectively.
• Market and Advertise Your Business: Marketing and advertising are critical to the success of your pharmaceutical wholesale business. Consider a multi-channel marketing strategy that includes online and offline marketing, as well as direct mail, email marketing, and social media marketing.
• Continuously Improve: The pharmaceutical industry is constantly evolving, and it is important to stay informed of industry trends and developments. Continuously improve your business by investing in research and development, as well as in the training and development of your employees.
• Seek Professional Advice: Finally, seek professional advice from experienced business consultants, legal experts, and financial advisors to help you start and grow your business. Their expertise and guidance can help you overcome challenges, make informed decisions, and achieve your goals.

In conclusion, starting a pharmaceutical wholesale business can be a challenging but rewarding venture. It is important to conduct market research, create a solid business plan, understand the legal and regulatory requirements, secure appropriate financing, build a strong team, have a well-thought-out operations and logistics plan, and effectively market and advertise your business. Additionally, staying informed of industry trends and adopting best practices can help ensure the success of your business. For aspiring entrepreneurs with a passion for the pharmaceutical industry, starting a wholesale business can be a fulfilling opportunity to bring essential drugs and healthcare products to those in need.

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

How to Start Pharmaceutical Business

Search this blog, how to grow your pharma business, how to start distribution business in pharmaceutical sector.

• Distribution of Pharmaceutical Company
• Wholesale Drug license Number
• Goods and Service Tax Identification Number
• FSSAI License  (If doing Food and Dietary Supplement distribution also)

Distribution of Pharmaceutical Company:

Procedure for taking distribution of a pharmaceutical company:, wholesale drug license number:, requirements: .

• Shop or premises having minimum of 10 square meter covered area with cemented walls and concrete roof.
• Either you or your partner or authorized person should possess minimum of registered pharmacist or EP certificate.
• Qualification for eligibility of EP certification is graduation with at least one year of experience at any pharmaceutical distribution firm.

Documents: 

• Application form at prescribed format
• Pharmacist/EP registration copy
• Appointment letter of pharmacist or EP (In case of if you or your partner don’t have required qualification)
• Prescribed Fee
• Address proof Copy of proprietor/partners/EP/Pharmacist
• Date of birth proof copy of EP/Pharmacist
• Academic qualification certificate copy of EP/Pharmacist
• Salary statement/experience certificate at letter pad in case new EP certificate
• Premises possession proof i.e. registry copy, rent agreement etc
• Refrigerator purchase bill photocopy
• Affidavit of EP/Pharmacist
• Constitution of Firm/Partnership deed for partnership firm/Registration firm receipt copy for private registration firm and list of directors with address proof, Memorandum of article of association etc
• Affidavit of proprietor/partners/directors
• Blueprint/layout plan of premises with signature in 3 copies
• Adequate storage facilities required including cupboards with glass doors, racks, pallets, refrigerator etc.

Steps involved in Starting Pharmaceutical Distribution Business:

• Prepare a Business Plan
• Constitution of proprietorship firm/partnership firm/registered firm 
• Complete all requirement and documents as mentioned above
• Apply for wholesale drug license number
• Apply for Goods and Services Tax Number
• Take distribution of pharmaceutical company/s
• Build a strong distribution channel
• Start Distribution of pharmaceutical products

Meidance is ready and on cn print my logo

Post a Comment

Ayurvedic medicine company.

Send Distribution/Franchise Query

• Take Ayurvedic Distribution
• Top Ayurvedic Pcd Franchise Company

Become Ayurvedic Distributor

Ayurvedic e-commerce shop.

• Buy Ayurvedic Products Online

Popular posts from this blog

What are the schedules under drug and cosmetic act, 1940 & rules 1945, state pharmacy council, its constitution and composition and functions, schedule f, f1, f2, f3, ff.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Post Topics

How to start a pharmaceutical company in 3 easy steps.

The pharmaceutical industry is booming. Scientific and technological advances are driving pharmaceutical innovation like never before. But what does this mean for you? It means there are more opportunities than ever for those looking to break out and start their own pharmaceutical distribution business.

Pharmaceutical distribution companies can most easily be described as the middleman between the drug manufacturing company and the retail pharmacy or end user. This industry is recession proof, making it an incredibly advantageous venture for any savvy entrepreneur. But it can be difficult to understand exactly how to start a pharmaceutical distribution company, navigating details right down to which pharmaceutical conveyors to use. That’s why we’ve put together a condensed, easy-to-understand guide for starting a safe pharmaceutical distribution business that can be successful long-term.

How to Start a Pharmaceutical Distribution Company

There are many steps and considerations involved when starting a pharmaceutical distribution company. The following is a brief overview:

• Hire a business consultant and determine your niche
• Research competitors
• Determine company structure
• Choose the right equipment
• Establish roles
• Conduct SWOT analysis
• Verify license requirements
• Establish your brand

Step 1: Stack The Deck In Your Favor

This is the first stage in planning your pharmaceutical distribution system and thus is twofold. This is when you build the true foundation of your company, which means having the right person (or people) in your corner and the right business in place.

• Start by hiring an experienced business consultant who fully understands the pharmaceutical industry. This person will be responsible for examining your overall business concept and determining if it would survive and thrive as it should.
• The second part is to thoroughly evaluate your business options. There are three routes you can take when starting your pharmaceutical distribution company:
• Begin a pharmaceutical business with a manufacturing unit
• Market medicines under your new brand name
• Team up with an established drug manufacturer

Keep in mind that whichever option you go with will fully depend on your overall budget and business goals.

Step 2: Create A Successful Business Plan

Once you’ve settled on the type of pharmaceutical distribution company you’re going to start, you need to create a business plan. While you can’t guarantee that it’s going to be a successful plan, you can set your business up in a smart way to better your chances of success.

Research Potential Competitors

Research is a key step in the process of setting up your business. Knowing your competitors will give you a good idea of where and why they excel — and what they could improve upon. By studying their business model, you’ll be better equipped to come up with something even better.

Identify Upfront Expenses

Crunch the numbers and determine the total investment that will be required to start a pharmaceutical distribution company. This includes deciding whether steps like manufacturing, trials or pharmaceutical distribution will happen in-house or will be outsourced. Plan out everything that will be needed, including (but not limited to):

• A production facility
• An office space or building
• Utilities (electricity, gas, water, Wi-Fi, etc.)
• Lab equipment
• Office supplies
• Employee wages
• Pharmaceutical industry conveyors
• Pharmaceutical conveyor belts

Choose the Right Equipment

As mentioned above, choosing the right equipment is vital to running a reputable pharmaceutical distribution company. That includes any manufacturing and packaging equipment, including the appropriate conveyor belts for pharmaceuticals .

The best pharmaceutical conveyors will not only help ensure safety but also enhance efficiency. For example, you can eliminate potential tracking issues with the Span Tech EZSpan Belt Conveyor system and sort and merge with ease with the High Speed Switch .

You’ll also need to ensure your equipment doesn’t damage your product. The MiniLink chain conveyor system was specially designed to move small, delicate pills or packaging with care. These and all of Span Tech’s conveyors were thoughtfully designed and can be fully customized to alleviate potential manufacturing risks while improving overall workflows.

Establish Roles And Responsibilities

Running a pharmaceutical distribution company is not something that can be done with just a handful of people. You’ll need a full staff of qualified, knowledgeable and enthusiastic employees who have the same vision for the company as you do. This needs to be factored into your business plan and your total investment. Some roles that are vital to starting your business include:

• A chief executive officer
• A human resources manager and/or department
• An inventory manager
• A purchasing manager
• A customer service executive and/or team
• An accountant or accounting department
• Various marketing and sales executives
• Floor manager(s)
• Floor employees
• Security guard(s)
• Truck driver(s)

It takes a lot of people to run a company. But by having the right team in place, you’ll alleviate a lot of the stress that can come with starting your own business.

Conduct SWOT Analysis

A SWOT analysis is where you take a hard look at your business plan’s strengths, weaknesses, opportunities and threats. In addition to completing a SWOT analysis of your own pharmaceutical distribution company, make sure to do one for each of your major competitors as well. This will give you a great overview and comparison of the market and where and how you fit into it.

Verify License Requirements

It’s vital when starting out that you research and acquire all necessary licenses for your city and state. The pharmaceutical distribution requirements will depend on your type of business but, in general, pharmaceutical startups are considered limited liability corporations. To find full listings of required licenses and permits, visit the U.S. Small Business Administration (SBA) website , the regional SBSA office and the Food and Drug Administration (FDA) website .

Step 3: Establish Your Brand

Once you’ve started your company, it’s time to take the proper steps to promote it by establishing a brand. Breaking into the pharmaceutical distribution industry and getting your products in front of the medical community can feel like a Herculean task. But by doing your research and investing in advertising and marketing, you’ll be one step closer to building a successful company. Advertising and marketing companies can help you create everything you need to get your name out there:

• A brand image
• A company mission
• A marketing campaign

If you have the budget for it, a PR agency or a designated marketing communications team can also be invaluable to your business in the long term.

Understand that building your pharmaceutical distribution business will take a lot of time, money and work. But by taking the right steps, hiring the right team and using the right equipment, you’ll be well on your way to running a successful company.

Start Your Company Off Right With Span Tech Pharmaceutical Conveyors

Span Tech’s proven pharmaceutical conveyors and components are used to safely transport medication, small vials, bottles, vial pucks, blister packs, tubes, bags, small cartons and more. Browse our entire selection of pharmaceutical conveyors and solutions to build your company for success. Have a question or need more information? Contact our customer service team today. Whatever your needs may be, we can help design a custom pharmaceutical distribution system that can help make your business a success.

Similar Articles

Span tech nominated for coolest thing made in kentucky.

Seth Bailey | March 14, 2024

OSHA Conveyor Safety Standards: A Roadmap for Ensuring Safe Practices

Span Tech | December 13, 2023

What Is an Accumulation Conveyor? A Comprehensive Guide to Accumulation Conveyor Systems

Span Tech | November 13, 2023

Upmetrics AI Assistant: Simplifying Business Planning through AI-Powered Insights. Learn How

Entrepreneurs & Small Business

Accelerators & Incubators

Business Consultants & Advisors

Educators & Business Schools

Students & Scholars

AI Business Plan Generator

Financial Forecasting

AI Assistance

Ai Pitch Deck Generator

Strategic Planning

See How Upmetrics Works  →

• Sample Plans
• WHY UPMETRICS?

Customer Success Stories

Business Plan Course

Small Business Tools

Strategic Planning Templates

E-books, Guides & More

• Sample Business Plans
• Medical & Health Care

Pharmacy Business Plan

Many pharmacists dream of opening their pharmacies. But more often than not, the collection of funds and resources becomes an overwhelming and off-putting process.

But it doesn’t need to be. A pharmacy business plan can help you at every step of setting up your pharmacy business.

If you are planning to start a new pharmacy business, the first thing you will need is a business plan. Use our sample Pharmacy Business Plan created using Upmetrics business plan software to start writing your business plan in no time.

Before you start writing a business plan, spend as much time as you can reading through some samples of medical and health-related business plans .

Industry Overview

The pharmaceutical industry stood at a market value of 1.27 trillion dollars in 2020 and has shown remarkable growth in the past two decades.

The advancement of research and development in the medical field has played a significant role in the growth of the pharmaceutical industry. Also, better production and distribution have changed the way people get medicines.

From online pharmacies to home deliveries, the face of the pharmacy industry has changed and become more convenient.

Also, with the growth of access to information, it has become more competitive too. But if done the right way, the pharmacy business is an extremely profitable one as well.

Say goodbye to boring templates

Build your business plan faster and easier with AI

Plans starting from $7/month

Things to Consider Before Writing a Pharmacy Store Business Plan

Check your legal requirements.

A pharmacy business requires a fair amount of licenses and permits. It is good to have a checklist of all the required licenses and to see if you have to get any of them.

Research what permits your state requires as well as the ones mandatory for everyone. It helps you stay on the good side of the law.

Pick a good location

A pharmacy setup requires a fixed minimum area. Also, a pharmacy that is easily accessible is more likely to succeed than one which is unreachable during emergencies. Hence, picking a good location is important .

Also, you can pick between starting a physical store or going online. Both business structures would have their pros and cons. You should pick the one that is the best for you.

Have a proper storage facility

Different medicines and formulas have different storage requirements. You’ll keep most of them in cool and dry places though. Bad storage can cost a pharmacy business dearly, even if you do everything else right.

Hence, it is important to have a good and ideal storage facility before you get started.

Check if your staff has the proper technical knowledge

You need technical knowledge and attention to detail to fare well as a pharmacist and so does your staff. As dealing with medicines is quite a critical job and can have consequences if not done right, it is important to find staff who know what they are doing and are well-trained and up to the job.

After you figure out some of the technical requirements, it is essential to figure out the business side of running a pharmacy. Planning, in the beginning, can save you from a lot of trouble later on.

Chalking Out Your Business Plan

A business plan helps you stay prepared for challenges, make better decisions, and formulate better business strategies. A pharmacy business takes a fair amount of legal procedures and competitive strategies, a pharmacy business plan can help you with that.

Reading some sample business plans will give you a good idea of what you’re aiming for. Also, it will show you the different sections that different entrepreneurs include and the language they use to write about themselves and their business plans.

We have created this sample pharmacy business plan for you to get a good idea about how perfect a pharmacy business plan should look and what details you will need to include in your stunning business plan.

Pharmacy Business Plan Outline

This is the standard business plan outline which will cover all important sections that you should include in your business plan.

• Keys to Success
• Business Ownership
• Summary Chart
• Business Model Description
• Mail order customers
• Walk-in customers
• Target Market Analysis
• Target Market Segment Strategy
• Competitive Edge
• Marketing Strategy
• Sales Forecast
• Development Requirements
• Personnel Plan
• Important Assumptions
• Break-even Analysis
• Projected Profit and Loss
• Projected Cash Flow
• Balance Sheet

Let’s understand how you can write each section of the pharmacy business plan.

1. Executive Summary

The executive summary section forms the first page of your business plan. It summarises all that your business stands for.

The executive summary section consists of the following subsegments:

• Objectives : This segment consists of the reason you started your business in the first place. What is your idea behind it and what problem do you plan on solving with it?
• Mission : Your mission statement should reflect how your pharmacy business can help people, apart from providing them with medicines. It reflects how your idea can deal with a problem more optimally.
• Financial Summary : This section would consist of the funding requirements of your business, and how the said funds would be put to use. It serves the main purpose of the executive summary, which is to get your business funded.

As a pharmacy business, your executive summary would consist of the type and size of your pharmacy business, your team, your qualifications and licenses, and a summary of your financial plan.

2. Products and Services

This section consists of a description of all the products and services your pharmacy offers.

For example, apart from your general products, this section can also consist of services your pharmacy offers like home delivery of medicines, subscription packages, online orders, etc.

3. Market Analysis

Market analysis helps you understand what you are getting yourself into. It also helps you make sense of all the research you have done and how you can put it to use for your business.

It consists of the following subsegments:

• Market Segmentation : Through market segmentation, you separate your target audience from the rest of the market based on their age, gender, income, occupation, medical conditions, etc.
• Market Positioning : In this segment, you can add an analysis of where you stand in the current market. And what would be the best marketing strategy for you as per your position?
• Target Market Analysis : In this section, you’ll write down an analysis of your target market, and their tastes and preferences.

As a pharmacy business, you can list down the type of pharmacy you own, your target customer base, the kind of services they like, the location they’ll prefer, and how they buy their medical supplies.

4. Strategy And Implementation

After you carry out market analysis, the next step would be to create a marketing strategy based on the same. This section helps you promote your business to your target audience.

This section consists of the following subsegments:

• Competitive Edge : Include your competitive advantage in this section. Include how your product is better than your competitor’s and how you’ll use that to your advantage.
• Marketing Strategy : Your marketing strategy should speak to your target audience. Your campaign should show your customers how your business solves a pressing problem.
• Sales Strategy : A sales strategy should be formulated after surveying what works best for your specific industry.

As a pharmacy business, you can center your marketing around safe products, better service, and availability. According to various surveys, KAM, clinical sales force, and service rep model are three of the most successful strategies for pharmacies.

5. Web Plan

With everything going online, a website strategy is of utmost importance. With online pharmacies like mail, my prescriptions, and Amazon pharmacy coming up, having an online presence is crucial to being seen by your consumers.

Moreover, an eCommerce website can also serve as a good alternative if you don’t want to go through the hassle of owning a physical store.

Nonetheless, building your online presence can help you in getting noticed. It is also a good method of promoting your brand idea.

6. Financial Plan

This section would consist of everything about your company’s finances. From your financial history to your projected profits, your financial plan would cover it all.

A good financial plan helps your business survive and thrive.

This segment consists of the following subsegments:

• Financial Resources : This segment would consist of the investment you can put in your business, as well as other resources for meeting your funding requirements.
• Funding Requirements : This would consist of the funding requirements to set up your pharmacy and keep it going.
• Projected Cash Flow and Profits : This section would consist of your business’s expected cash flow and profits in the long term.

Download a sample pharmacy business plan

Need help writing your business plan from scratch? Here you go;  download our free pharmacy business plan pdf  to start.

It’s a modern business plan template specifically designed for your pharmacy business. Use the example business plan as a guide for writing your own.

The Quickest Way to turn a Business Idea into a Business Plan

Fill-in-the-blanks and automatic financials make it easy.

Pharmacy Business Plan Summary

In conclusion, though a pharmacy business might take a lot of work, you can make running your business a lot easier and smoother with a business plan.

A business plan helps you stay organized and updated as per market trends and changing environment of the industry.

After getting started with Upmetrics , you can copy this sample pharmacy business plan template into your business plan and modify the required information and download your pharmacy business plan pdf or doc file.

It’s the fastest and easiest way to start writing your business plan.

Related Posts

Telemedicine Business Plan

Medical Billing Business Plan

400+ business plan example

Urgent Care Business Plan

Table of Contents in Business Plan

Guide for Customer Analysis in Business Plan

About the Author

Upmetrics Team

Upmetrics is the #1 business planning software that helps entrepreneurs and business owners create investment-ready business plans using AI. We regularly share business planning insights on our blog. Check out the Upmetrics blog for such interesting reads. Read more

Plan your business in the shortest time possible

No Risk – Cancel at Any Time – 15 Day Money Back Guarantee

Popular Templates

Create a great Business Plan with great price.

• 400+ Business plan templates & examples
• AI Assistance & step by step guidance
• 4.8 Star rating on Trustpilot

Streamline your business planning process with Upmetrics .

Pharmacy Business Plan Template

Written by Dave Lavinsky

Pharmacy Business Plan

You’ve come to the right place to create your pharmacy business plan.

We have helped over 10,000 entrepreneurs and business owners create business plans and many have used them to start or grow their pharmacies.

Pharmacy Business Plan Example

Below is a sample pharmacy business plan and template to help you create each section of your pharmacy business plan.

Executive Summary

Business overview.

Healthy1 Pharmacy is a new independent retail pharmacy located in Charleston, South Carolina. The company is founded by Stephen Harris, a licensed pharmacist who has spent more than fifteen years working in the pharmacy industry. Stephen is confident that his strong communication skills combined with his keen attention to detail when preparing prescriptions will help him quickly grow a loyal customer base for his new pharmacy. Stephen has recruited a team of highly qualified professionals to help manage the day-to-day complexities of running a retail pharmacy including marketing, sales, customer service, financial reporting, and operations management.

Healthy1 Pharmacy will provide all of the products and services that are available at large retail chains, only with a better price and a small-town atmosphere. At Healthy1, sales associates and pharmacy technicians will get to know each customer by name and be able to offer a more personalized service not typically offered at larger pharmacies. Healthy1 Pharmacy will be a one-stop shop for any customer in need of a prescription, flu shot, OTC medication, and more.

Product Offering

The following are the services that Healthy1 Pharmacy will provide:

• Over-the-counter (OTC) medications
• Prescription medications
• Immunizations
• Travel medications
• Point-of-Care (POC) Tests
• Compounding

Customer Focus

Healthy1 Pharmacy will target all individuals in Charleston. The pharmacy will target multiple age groups from pediatric to geriatric. Healthy1 will also target patients needing prescriptions filled on a regular basis. No matter the customer, Healthy1 Pharmacy will deliver the best communication, service, and prices.

Management Team

Healthy1 Pharmacy will be owned and operated by Stephen Harris. He has recruited Emily Jackson, an experienced retail pharmacy manager to be his Store Manager and help to supervise the staff and run the day-to-day retail operations.

Stephen Harris is a licensed pharmacist with a Doctor of Pharmacy (PharmD) degree and more than fifteen years of experience working in the pharmacy industry. Stephen has been recognized by his former employer as a top performing pharmacist for five years in a row.

Emily Jackson has been a store manager at a local retail pharmacy for over a decade and has garnered a positive reputation for her exceptional organizational skills and leadership. Emily has worked in the pharmacy industry for so long, she understands all aspects required in running a successful retail pharmacy.

Success Factors

Healthy1 Pharmacy will be able to achieve success by offering the following competitive advantages:

• Friendly, knowledgeable, and highly qualified team of sales associates and pharmacy technicians who will assist customers, answer questions, and provide a personalized approach not found in larger pharmacies.
• Comprehensive array of products and services that includes everything you would expect from a large pharmacy, only with attentive customer service and lower prices.
• Healthy1 Pharmacy offers the best pricing in Charleston. The pharmacy’s pricing structure is the most cost effective compared to the competition.

Financial Highlights

Healthy1 Pharmacy is seeking $400,000 in debt financing to launch its new pharmacy. The funding will be dedicated towards securing the retail space and purchasing equipment, inventory, and supplies. Funding will also be dedicated towards three months of overhead costs to include payroll of the staff, rent, and marketing costs. The breakout of the funding is below:

• Pharmacy and retail space build-out: $100,000
• Equipment, supplies, inventory, and materials: $100,000
• Three months of overhead expenses (payroll, rent, utilities): $160,000
• Marketing costs: $25,000
• Working capital: $15,000

The following graph below outlines the pro forma financial projections for Healthy1 Pharmacy.

Company Overview

Who is healthy1 pharmacy.

Healthy1 Pharmacy is a newly established independent retail pharmacy located in Charleston, South Carolina. Healthy1 Pharmacy will provide all of the products and services that are available at large retail chains, only with lower prices and a small-town atmosphere. At Healthy1, sales associates and pharmacy technicians will get to know each customer by name and be able to offer a more personalized service not typically offered at larger pharmacies. Healthy1 Pharmacy will be a one-stop shop for any customer in need of a prescription, flu shot, OTC medication, and more. Healthy1 Pharmacy will be able to provide Charleson customers with the experience of a friendly, neighborhood drugstore while ensuring each prescription is handled with the highest standards of quality and care. The team of pharmacy technicians and sales associates will be highly qualified and experienced in helping customers find the right over-the-counter solutions for their individual needs as well as ensuring each prescription is filled accurately and efficiently.

Healthy1 Pharmacy History

Healthy1 is owned and operated by Stephen Harris, a licensed pharmacist with over fifteen years of experience working in the pharmacy industry. Stephen has worked for a large pharmacy chain and managed a team of pharmacy technicians for several years. Stephen’s tenure with the pharmacy chain combined with his pharmaceutical education has given him the skills and knowledge required to start his own pharmacy.

Since incorporation, Healthy1 Pharmacy has achieved the following milestones:

• Registered Healthy1 Pharmacy, LLC to transact business in the state of South Carolina.
• Has a contract in place to lease the retail storefront he will use for his pharmacy.
• Reached out to numerous contacts to include experienced pharmacy technicians and sales associates to advise them of the upcoming opportunities at his new pharmacy.
• Began recruiting the management team members including a store manager, an accountant/bookkeeper, and a marketing director.

Healthy1 Pharmacy Services

The following are the pharmacy products and services that Healthy1 Pharmacy will provide:

Industry Analysis

The pharmacy industry in the United States is valued at $534.2B and is projected to grow to $862B by 2028. Major market drivers include a growing number of types of diseases, an increasing percentage of people with chronic illnesses, an aging population, and higher healthcare costs.

There are more prescription medications being developed, and the demand for more prescriptions is growing faster than ever before. In 2020, there were an estimated 860M medications prescribed by physicians and 336M prescribed by hospitals. This prescription demand is resulting in more pharmacies opening across the U.S. The National Council for Prescription Drug Programs (NCPDP) reports an estimated 20,400 independent pharmacies in 2010. This number has grown to over 23,000 by 2019, a 12.9% increase in the number of independent pharmacies for that time period.

Industry operators in the pharmaceutical market can benefit from providing above average customer service, lower prices than competitors, and products or services that aren’t being offered elsewhere.

Customer Analysis

Demographic profile of target market.

Healthy1 Pharmacy will target all individuals in Charleston, South Carolina. The pharmacy will target multiple age groups from pediatric to geriatric. Healthy1 will also target patients needing prescriptions filled on a regular basis.

The precise demographics for Charleston, South Carolina are:

Customer Segmentation

Healthy1 will primarily target the following customer profiles:

• Parents of pediatric patients
• Geriatric patients
• People taking medications on a regular basis
• People needing compounding services
• People looking for vaccines or immunizations
• People who need lab tests

Competitive Analysis

Direct and indirect competitors.

Healthy1 Pharmacy will face competition from other companies with similar business profiles. A description of each competitor company is below.

Charleston Care Pharmacy

Charleston Care Pharmacy provides a wide variety of pharmacy products and services including OTC medications, lab testing, and compounding. Located in a senior neighborhood, Charleston Care Pharmacy specializes in serving the geriatric population, but welcomes customers of all ages. Charleston Care Pharmacy’s promise is to deliver effective communication, honesty, and integrity in every transaction. Charleston Care Pharmacy’s team of experienced pharmacy technicians assures customers are well taken care of and prescriptions are filled quickly and correctly.

FeelBetterNow Pharmacy

FeelBetterNowPharmacy is a Charleston-based neighborhood pharmacy that provides a full suite of services including compounding, vaccines, lab testing, local delivery, and more. The owners of FeelBetterNowPharmacy are licensed pharmacists who have extensive experience working for independent retail pharmacies so they understand what customers are looking for in a neighborhood pharmacy. Customers who choose FeelBetterNowPharmacy can rest assured they are getting the best quality products at reasonable prices.

Care Better Pharmacy

Care Better Pharmacy is a trusted Charleston pharmacy that is known for providing superior customer service. They are able to provide a one-stop shop for customers looking for convenient OTC and prescription medications, durable medical equipment, vaccines, and immunizations. Care Better Pharmacy is also able to serve customers in need of compounding, recurring prescriptions, and lab testing. They have expert pharmacy technicians to provide information about each medication and answer all of their customers’ questions.

Competitive Advantage

Healthy1 Pharmacy will be able to offer the following advantages over their competition:

• Healthy1 Pharmacy offers the best pricing in Charleston. The pharmacy offers its customers low prices on all of its products and services compared to the competition.

Marketing Plan

Brand & value proposition.

Healthy1 Pharmacy will offer the unique value proposition to its customers:

• Highly-qualified team of skilled pharmacy technicians and sales associates will be able to provide personalized customer service and ensure all prescriptions are handled with care.
• Unbeatable pricing to its clients – Healthy1 Pharmacy does not mark up its products and services at a large percentage. The pharmacy will offer the lowest prices guaranteed. If a customer finds a cheaper price elsewhere, Healthy1 Pharmacy will give the customer a better price.

Promotions Strategy

The promotions strategy for Healthy1 Pharmacy is as follows:

Healthy1 Pharmacy will create and maintain a company website that is well organized, informative, and lists all the products and services that Healthy1 is able to provide. The website will also list promotions and discounts, informative healthcare articles, and pharmacy-sponsored community events.

SEO/Google Marketing

The company’s marketing director will manage Healthy1’s website presence with SEO marketing tactics so that any time someone types in the Google or Bing search engine “Charleston pharmacy” or “pharmacy near me”, Healthy1 Pharmacy will be listed at the top of the search results.

Social Media Marketing

Healthy1 Pharmacy’s marketing director will also manage the company’s social media presence on several platforms including Instagram, Facebook, Twitter, YouTube, TikTok, and LinkedIn. The goal of the social media strategy is to attract new customers while engaging with current customers to encourage referrals, reviews, and feedback.

Content Marketing/Email Marketing

The company will post blogs and other promotional content on a regular basis with informative health and wellness information to keep people coming back. Healthy1 will post informative content on the website, social media platforms, and through email newsletters.

Professional Associations/Networking

Healthy1 Pharmacy will become a member of professional associations such as the Independent Retail Pharmacy Association, the National Community Pharmacists Association, and the Tennessee Pharmacists Association. The company will focus networking efforts on expanding its customer base.

Print Advertising

Healthy1 Pharmacy will invest in professionally designed print ads to display in programs or flyers at industry networking events, in magazines, direct mailers, and in local newspapers.

The pricing will be lower than competitors so customers feel they receive value when they choose Healthy1 products and services.

Operations Plan

The following will be the operations plan for Healthy1 Pharmacy.

Operation Functions:

• Stephen Harris will be the Owner and Lead Pharmacist. He will oversee pharmacy technicians. Stephen has spent the past year recruiting the following staff:
• Emily Jackson – Store Manager who will oversee all retail operations, sales associates, supplier relations, and inventory management.
• Jessica Johnson – Staff Accountant/Bookkeeper who will provide budgeting, tax payments, and financial reporting.
• Tim Thompson – Marketing Director who will provide marketing and sales campaigns for Healthy1 Pharmacy.

Milestones:

Healthy1 Pharmacy will have the following milestones complete in the next six months.

9/1/2022 – Finalize contract to lease the retail space.

9/15/2022 – Finalize personnel and staff employment contracts for the Healthy1 Pharmacy team.

10/1/2022 – Finalize contracts with suppliers.

10/15/2022 – Network at industry events and initiate the marketing and promotional campaign.

10/22/2022 – Begin moving into the Healthy1 Pharmacy storefront.

11/1/2022 – Healthy1 Pharmacy opens for business.

Stephen Harris is a licensed pharmacist with a Doctor of Pharmacy (PharmD) degree and more than fifteen years of experience working in the pharmacy industry. Stephen has been recognized for his commitment to excellence in filling prescriptions accurately and efficiently as well as his communication skills and positive rapport with customers.

Emily Jackson has been a store manager at another retail pharmacy for over a decade and has garnered a positive reputation for her exceptional organizational skills and leadership. Emily has worked in the pharmacy industry for so long, she understands all aspects required in running a successful retail pharmacy.

Financial Plan

Key revenue & costs.

The revenue drivers for Healthy1 Pharmacy are the fees charged to customers in exchange for the pharmacy’s products and services.

The cost drivers will be the overhead costs required in order to staff a pharmacy. The expenses will be the payroll cost, rent, utilities, inventory, supplies, and marketing materials.

Funding Requirements and Use of Funds

Healthy1 Pharmacy is seeking $400,000 in debt financing to launch its pharmacy business. The funding will be dedicated towards securing the retail space and purchasing equipment, inventory, and supplies. Funding will also be dedicated towards three months of overhead costs to include payroll of the staff, rent, and marketing costs. The breakout of the funding is below:

Key Assumptions

The following outlines the key assumptions required in order to achieve the revenue and cost numbers in the financials and in order to pay off the startup business loan.

• Number of prescriptions filled per month: 2,000
• Average fees collected each month: $50,000
• Retail lease per year: $100,000

Financial Projections

Income statement, balance sheet, cash flow statement, what is a pharmacy business plan.

A pharmacy business plan is a plan to start and/or grow your pharmacy  business. Among other things, it outlines your business concept, identifies your target customers, presents your marketing plan and details your financial projections.

You can easily complete your pharmacy business plan using our Pharmacy Business Plan Template here .

What are the Main Types of Pharmacy Businesses?

There are a number of different kinds of self storage business , some examples include: Pharmacy, Home Care Pharmacy, Mail Order Pharmacy and Compounding Pharmacy.

How Do You Get Funding for Your Pharmacy Business Plan?

Pharmacy businesses are often funded through small business loans. Personal savings, credit card financing and angel investors are also popular forms of funding.

What are the Steps To Start a Pharmacy Business?

Starting a pharmacy business can be an exciting endeavor. Having a clear roadmap of the steps to start a business will help you stay focused on your goals and get started faster.

1. Develop A Pharmacy Business Plan - The first step in starting a business is to create a detailed pharmacy business plan that outlines all aspects of the venture. This should include potential market size and target customers, the services or products you will offer, pricing strategies and a detailed financial forecast.  

2. Choose Your Legal Structure - It's important to select an appropriate legal entity for your pharmacy business. This could be a limited liability company (LLC), corporation, partnership, or sole proprietorship. Each type has its own benefits and drawbacks so it’s important to do research and choose wisely so that your pharmacy business is in compliance with local laws.

3. Register Your Pharmacy Business - Once you have chosen a legal structure, the next step is to register your pharmacy business with the government or state where you’re operating from. This includes obtaining licenses and permits as required by federal, state, and local laws. 

4. Identify Financing Options - It’s likely that you’ll need some capital to start your pharmacy business, so take some time to identify what financing options are available such as bank loans, investor funding, grants, or crowdfunding platforms. 

5. Choose a Location - Whether you plan on operating out of a physical location or not, you should always have an idea of where you’ll be based should it become necessary in the future as well as what kind of space would be suitable for your operations. 

6. Hire Employees - There are several ways to find qualified employees including job boards like LinkedIn or Indeed as well as hiring agencies if needed – depending on what type of employees you need it might also be more effective to reach out directly through networking events. 

7. Acquire Necessary Pharmacy Equipment & Supplies - In order to start your pharmacy business, you'll need to purchase all of the necessary equipment and supplies to run a successful operation. 

8. Market & Promote Your Business - Once you have all the necessary pieces in place, it’s time to start promoting and marketing your pharmacy business. This includes creating a website, utilizing social media platforms like Facebook or Twitter, and having an effective Search Engine Optimization (SEO) strategy. You should also consider traditional marketing techniques such as radio or print advertising.

Learn more about how to start a successful pharmacy business:

• How to Start a Pharmacy Business

Where Can I Get a Pharmacy Business Plan PDF?

You can download our free pharmacy business plan template PDF here . This is a sample pharmacy business plan template you can use in PDF format.

Free Download

Pharmacy Business Plan Template

Download this free pharmacy business plan template, with pre-filled examples, to create your own plan..

Or plan with professional support in LivePlan. Save 50% today

Available formats:

What you get with this template

A complete business plan.

Text and financials are already filled out and ready for you to update.

• SBA-lender approved format

Your plan is formatted the way lenders and investors expect.

Edit to your needs

Download as a Word document and edit your business plan right away.

• Detailed instructions

Features clear and simple instructions from expert business plan writers.

All 100% free. We're here to help you succeed in business, no strings attached.

Get the most out of your business plan example

Follow these tips to quickly develop a working business plan from this sample.

1. Don't worry about finding an exact match

We have over 550 sample business plan templates . So, make sure the plan is a close match, but don't get hung up on the details.

Your business is unique and will differ from any example or template you come across. So, use this example as a starting point and customize it to your needs.

2. Remember it's just an example

Our sample business plans are examples of what one business owner did. That doesn't make them perfect or require you to cram your business idea to fit the plan structure.

Use the information, financials, and formatting for inspiration. It will speed up and guide the plan writing process.

3. Know why you're writing a business plan

To create a plan that fits your needs , you need to know what you intend to do with it.

Are you planning to use your plan to apply for a loan or pitch to investors? Then it's worth following the format from your chosen sample plan to ensure you cover all necessary information.

But, if you don't plan to share your plan with anyone outside of your business—you likely don't need everything.

More business planning resources

How to Start a Business With No Money

How to Write a Business Plan for Investors

Business Plan Template

How to Write a Business Plan

Simple Business Plan Outline

How to Create a Business Plan Presentation

10 Qualities of a Good Business Plan

Industry Business Planning Guides

Download your template now

Need to validate your idea, secure funding, or grow your business this template is for you..

• Fill-in-the-blank simplicity
• Expert tips & tricks

We care about your privacy. See our privacy policy .

Not ready to download right now? We'll email you the link so you can download it whenever you're ready.

Download as Docx

Download as PDF

Finish your business plan with confidence

Step-by-step guidance and world-class support from the #1 business planning software

From template to plan in 30 minutes

• Step-by-step guidance
• Crystal clear financials
• Expert advice at your fingertips
• Funding & lender ready formats
• PLUS all the tools to manage & grow

The quickest way to turn a business idea into a business plan

Fill-in-the-blanks and automatic financials make it easy.

No thanks, I prefer writing 40-page documents.

Discover the world’s #1 plan building software

Ready for launch: Reshaping pharma’s strategy in the next normal

As COVID-19 cases continue to spread across the globe, the repercussions in healthcare extend across the value chain from patients and families to clinicians and pharmaceutical companies.

The industry faces a dual challenge. As well as helping to tackle COVID-19 spread by developing and distributing new vaccines and tests, it must continue to deliver innovative therapies and diagnos­tics to clinicians, patients, and healthcare systems—even as R&D, manufacturing, and supply chains are struggling to maintain business as usual.

An earlier McKinsey article considered how pharma companies can reorient their commercial model to respond to the new environment. Below, we focus on launch activities and identify five success factors to consider for commercial launches in the next normal.

Familiar challenges and new complications

Even before the COVID-19 outbreak, launching a new drug was far from straightforward. Forty percent of worldwide drug launches between 2009 and 2017 failed to meet their two-year sales forecasts. 1 McKinsey analysis of pharmaceutical-industry data from Evaluate, August 2020. A successful launch must overcome a series of barriers, including intensifying competition, increasing pricing pressure, growing access challenges, and rising expectations among caregivers and patients. The pandemic and its economic consequences have added further complications to what was already a risky launch environment.

We analyzed 86 launches scheduled for 2018 onward with expected sales in excess of $300 million. We found that between February and August 2020, all of these launches were disrupted through delays, lost revenues, or both. Companies chose to delay launches in 45 percent of cases, regulatory delays affected another 40 percent, and other external factors such as supply-chain problems accounted for the remaining 15 percent of delays. 2 This article draws on insights from a global survey conducted by McKinsey in June 2020 among 101 managers with recently launched drugs that had not reached their peak sales or drugs scheduled for launch between January and June 2020 that had been delayed. In the United States, for instance, the median interval between approval and first scripts had increased more than threefold by May 2020, from 17 to 58 days, although it shrunk back to 21 days by September. 3 McKinsey analyzed products launched from March 2020 or awaiting launch, using data from PHAST (Pharmaceutical Audit Suite) and Evaluate. For products not yet launched, the interval between the FDA-approval date and September 2020 was used as a proxy for the interval between approval and launch.

The pandemic also had a marked impact on the financial performance of the launches we analyzed. In 50 out of the 86 disrupted launches, companies lowered their expectations by more than 25 percent. Overall, we estimate that the changes in analyst consensus expectations between March and August 2020 represent a 9 percent decline in the net present value of the 86 drugs—the equivalent of a total loss of some $10 billion globally. 4 McKinsey used August 2020 data from Evaluate and estimates from March 2020 or earlier to calculate how the net present value of the 86 drugs changed in the months following the outbreak of COVID-19.

Why the traditional launch model is losing effectiveness

It is too soon to evaluate the full impact of the COVID-19 pandemic on drug launches. However, it is clear that major shifts in the way that healthcare professionals (HCPs) interact with pharma companies will present a challenge for the traditional launch model, with its reliance on face-to-face meetings with physicians and its “one size fits all” approach to engagement.

One immediate consequence of the pandemic has been a drastic reduction in pharma companies’ visits to HCPs. A survey conducted by McKinsey in Europe shows that the average number of in-person contacts between HCPs and pharma sales reps was 70 percent lower in September 2020 than before the pandemic. 5 McKinsey COVID-19 Survey: EU Physician Experiences, Expectations, and Perspectives on Pharma Engagement; survey in the field in May and September 2020. In parallel, HCPs’ adoption of digital channels and telemedicine has accelerated for interactions with patients and pharma reps alike. In the same survey, the HCPs who are highly open to remote engagement with sales reps report conducting almost half of their patient consultations remotely as well.

However, this broad overview masks considerable differences in HCPs’ preferences and expectations. A McKinsey survey conducted in May and September 2020 to assess sentiment among more than 900 physicians in five European countries yielded a patchwork of responses (Exhibit 1).

Only 18 percent of the physicians surveyed in May were willing to accept reps’ visits, but by September, that percentage had risen to 31 percent, suggesting that preferences shift over time as infection rates change and HCPs adjust to new circumstances. 6 McKinsey COVID-19 Survey: EU Physician Experiences, Expectations, and Perspectives on Pharma Engagement; survey in the field in May and September 2020. Preferences also vary by country. In the September survey, more than 50 percent of HCPs in France, Germany, and Italy expressed a willingness to accept regular face-to-face visits from reps, but only 11 percent of their UK peers felt the same way.

These findings suggest that the traditional pharma commercial model will likely struggle to adapt to a different world. When reps venture back into the field, they will need to address the plurality and access challenges of the new interaction landscape. To do that, they will need to consider a new approach to launches: one that is digital, local, and personalized.

What next? Five success factors to consider for a launch strategy

For a pharma company looking to reinvent its commercial model, the launch of new products is a golden opportunity to try out new techniques and gauge their impact before rolling them out more widely. Given the uncertainties triggered by the pandemic and the radical changes in physicians’ preferences and behaviors, replicating successful launch strategies from the past is no longer a safe option. Our work with pharma companies indicates that leaders designing a new strategy should consider paying close attention to five success factors: rapidly personalized content, analytics-enabled engagement, innovative patient channels and services, nimble frontline operations, and closed-loop execution (Exhibit 2). We outline each of these five factors in greater detail below.

Rapidly personalized content

With HCPs’ preferences so variable and changeable, pharma companies need clear, up-to-date per­spectives on each physician’s interests and wishes so they can gear messages to individual needs and concerns. Basing communications on an undifferentiated aggregate view of physicians or segments will no longer suffice. For each new product launch, best-practice companies compile a set of marketing and medical modules to cover the full spectrum of HCP needs and then ask reps to use their insight into individual physicians to select the modules that best meet their needs.

While this approach has been true for many years, the difference is that today those new modules need to be created quickly to be relevant. A better way to stay relevant is to engage HCPs on the current hot topics in their field—for example, what best practices are emerging in telemedicine? How are HCPs managing COVID-19 infection risk for patients? What do key opinion leaders think about the potential for drug-to-drug interactions with COVID-19 vaccines?

Familiar product-oriented and company-centered approaches to content may also need rethinking. To reduce development cycles, content creation and review processes need to be streamlined and simplified. With agile approaches, companies can book a meeting with an HCP, gather feedback, and capture it immediately in the next iteration of content development. In that way, content can be approved and refined within approval cycles of no more than two to four weeks.

For a pharma company looking to reinvent its commercial model, the launch of new products is a golden opportunity to try out new techniques and gauge their impact before rolling them out more widely.

Analytics-enabled engagement

If a universal approach is no longer an option for content, the same is true of engagement. The days of casual appointments and conversations in hallways are over. Whether an interaction is face to face or remote, it needs to be scheduled and an agenda shared in advance. A rep needs to have something new and compelling to discuss or risks that the meeting might never happen.

To understand individual physicians’ preferences for interaction frequency and channels, innovative companies are creating data lakes, building predic­tive models, and drawing on unfamiliar data sources—not only customer-relationship-management (CRM) systems, sales records, and quantitative surveys, say, but also claims data for providers at a physician’s office. Innovative approaches can yield surprising results. In the United States, for instance, some pharma com­panies found they can predict physicians’ willingness to engage with reps more accurately from foot traffic and credit-card spend in a given zip code than from local state restrictions or COVID-19 infection rates.

Since relevant historical data on physician prefer­ences on interactions with sales reps is seldom available at launch, the process of generating insights typically begins with field reps reporting on the impressions they gained of HCPs’ preferences during prelaunch interactions with them. As the product launch progresses, important factors such as physi­cian feedback, field insights, and prescription volume are used to flesh out and update this prelimi­nary picture. Through a continual process of refinement, the predictive model on launch success becomes more powerful and its output better aligned with the realities of the market. As a physician’s preferences evolve—both in response to the new product as well as in engagement channels—the model adjusts its recommendations, enabling reps to fine-tune content and channel choices for an audience of one to provide an optimal personalized experience at launch.

To implement an analytics-based approach to engagement, pharma leaders also need to ensure that two critical enablers are in place: a tech and data backbone to enable seamless integration across channels and data sources, and a platform for run­ning advanced-analytics models to enable leaders to distinguish signals from noise, improve deci­sion making in real time, and optimize messages, channels, and timing in individual HCP interactions.

Innovative patient channels and services

In a McKinsey survey of 300 physicians in September 2020, 74 percent of respondents reported noticing their patients delaying necessary care, with conse­quences including an increase in complications from injury or disease, a loss of income from missing work, and a rise in the costs of care. For new product launches, this finding is significant, since patients who have yet to be treated for a new medical condition are often the ones most interested in a new product for treat­ment. However, as patients delay care due to the COVID-19 pandemic, the pool of new patients that may have benefited from being treated with a new product is declining as well. The new hurdles created by the COVID-19 pandemic call for innovative services from pharma companies, as well as from healthcare systems and professionals, to stay connected with patients.

As the survey indicates, the perceived risk of engag­ing with health systems has made many patients wary of face-to-face interactions in all but the most serious cases. Those suffering from nonurgent conditions, such as migraines, insomnia, and depres­sion, are less likely to request appointments with primary-care physicians. Responsive companies have been stepping in to facilitate inter­actions with HCPs by offering telemedicine diagnostic platforms in app form or through the integration of web, text, and voice.

Maintaining or adjusting treatment can also be dif­ficult in today’s circumstances, especially for infusions, injections, and other therapies that require attendance at a hospital or clinic. Innovative companies are developing alternative infusion sites, enabling “at home” infusion, and offering guidance on how to minimize risk when visiting health facilities.

Nimble frontline operations

As pharma companies gear up for remote launch activities, they can help their sales reps build new capabilities that can enhance their impact on launch success. As virtual calls replace in-person visits, reps can foster a sense of proximity with HCPs by learning to make the most of cameras, screen sharing, and other interaction tools. Soft skills such as deep listening will help sales reps gather insights on physicians’ unmet needs and sources of dissatisfaction. Feeding these insights back into CRM systems will enhance their predictive power and enable the organization to rapidly correct course where needed.

As the use of video, interactive content, and multi­person interactions increases, companies will also need to rethink marketing materials so that they are effective in remote settings. Meanwhile, marketing staff will need to further develop their ability to optimize marketing campaigns based on HCP engagement, as well as using CRM data and dashboards to assess the effectiveness of past and future actions. Capability-building programs will equip staff with the soft and hard skills— from empathy to proficiency with advanced digital tools—required for success in a rapidly changing launch environment.

Capabilities aside, launch programs give companies an opportunity to reassess the setup of their field force. With less time spent traveling and waiting to see HCPs, reps have more capacity to pursue value-added opportunities. One example might be expanding physician engagement beyond the treatment network—through referral networks, for instance—especially now that location is no longer a constraint. Building a fuller view of customer-facing roles and interactions should allow launch leaders to allocate frontline capacity in a more effective and granular manner.

Closed-loop execution

Today’s environment makes agile ways of working a necessity. With launches no longer following a common regional or national strategy but tailored to suit local contexts, each initiative must be tracked and redirected in real time as early feedback and results on sales tactics are gathered. This kind of closed-loop execution requires changes in governance and in how decisions are made.

For instance, regional leads should be empowered to fine-tune targeting philosophy and product positioning in response to the feedback they gather locally. Meanwhile, central launch teams can share best practices or make suggestions by aggregating the success rate of different approaches across various target segments and regions. Campaigns that prove effective can be scaled up across broader geographies, while ineffective campaigns can be replaced with new campaigns that are tested and, in turn, refined or replaced as needed based on their results. Consequently, launch plans are updated in rapid iterations at national and regional levels to ensure that insights and opportunities are fully captured. To manage this process and experiment with new methods and ways of working, some companies set up launch situation rooms  that pull together data on sales, volume uptake, and other standard metrics with field insights garnered through rep apps to analyze launch performance in real time. Adopting an agile operating model with processes that support cross-functional collaboration enables launch teams to rapidly create campaigns to address shifting customer needs.

The turbulence of the past few months has made pharma companies keenly aware of the need to rethink their medical education, engagement channels, and platforms—but it has also left some of them paralyzed by uncertainty. Should they invest now in transforming their commercial model or wait to see how things play out? As com­mercial leaders consider their go-to-market plans for new drugs, they have a unique opportunity to experiment with new approaches without disrupting their entire business model. Innovations developed for new drugs that prove valuable for commercial success will reshape the commercial strategy of the whole company.

Arafat Mlika is an associate partner in McKinsey’s Geneva office, Jennifer Mong is a consultant in the Silicon Valley office, Nils Peters  is a partner in the Zurich office, and Pablo Salazar is a partner in the Stamford office.

Explore a career with us

Related articles.

COVID-19 and commercial pharma: Navigating an uneven recovery

Winning against COVID-19: The implications for biopharma

Drug Prescription Delivery Business Plan [Sample Template]

By: Author Tony Martins Ajaero

Home » Business ideas » Healthcare and Medical » Pharmacy

Are you about starting a drug prescription delivery company? If YES, here is a complete sample drug prescription delivery business plan template & feasibility report you can use for FREE .

Okay, so we have considered all the requirements for starting a drug prescription delivery business. We also took it further by analyzing and drafting a sample drug prescription delivery business marketing plan template backed up by actionable guerrilla marketing ideas for drug prescription delivery businesses. So let’s proceed to the business planning section.

Pharmacy business is indeed a thriving business and if you want to run a pharmacy related business, you should consider starting a drug prescription delivery business.

When starting a drug prescription delivery business, you will need robust business relationship with pharmaceutical manufacturing companies and also retail pharmacy stores in and around your target location.

The truth is that the drug prescription delivery business is still open for investors to come in and compete for the available market in the country you intend launching the business.

If you are sure this type of business is what you truly want to do after you must have conducted your feasibility studies and market research, then the next step to follow is to write a good business plan; a detailed blueprint of how you intend raising your seed capital, setting up the business, managing the flow of the business, sorting out tax and marketing your products.

The truth is that it is one thing to have a fantastic idea cum business plan, but another thing for the business plan to translate to profits, which is why it is important to assemble a team of dedicated workers to work with if you want to be successful with your drug prescription delivery business.

Below is a sample drug prescription delivery company business plan template that will help you successfully write yours without much stress

A Sample Drug Prescription Delivery Business Plan Template

1. industry overview.

Drug prescription delivery business is part of the Pharmacy & Drug Store Franchises industry and this industry is made up of businesses that are into Generic drug prescriptions, brand-name drug prescriptions, over-the-counter medicines, personal hygiene and cosmetic products, groceries and other food items, health aids and home healthcare equipment etc.

A prescription drug which can also be called prescription medication or prescription medicine is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Over-the-counter drugs on the other hand can be obtained without a prescription.

The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Please note that in the united states of America, each jurisdiction has different definitions of what constitutes a prescription drug.

All over the world, the pharmaceutical industry is highly regulated because the devastating effect of fake drugs or drug abuse is alarming. As a matter of fact, there are several universal laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.

For example, in the United States, new pharmaceutical products must be approved by the Food and Drug Administration (FDA) as being both safe and effective before they can be allowed to go into the market.

Statistics has it that global spending on prescription drugs grew to a whopping sum of $954 billion in 2011 and the United States accounts for more than a third of the global pharmaceutical market, with an estimate of $340 billion in annual sales

Statistics has it that in the United States alone, the industry generates over $6 billion annually from more than 1,451 registered and licensed generic pharmacy & drugs store franchise (drug prescriptions delivery business inclusive) scattered all around the country.

The industry is responsible for the employment of over 14,666 people. Experts project the industry to grow at a 3.4 percent annual rate from 2013 to 2018. In the United States, the companies holding the largest market share in the Pharmacy & Drug Store Franchises industry are McKesson Corporation and Cardinal Health Inc.

A recent report published by IBISWORLD shows that operators in this industry are not independent pharmacies or drug stores; they are retail locations operating under franchise agreements that dictate the terms and conditions under which they operate and market themselves.

The industry as a whole has experienced stable growth over the past five years due to steady demand for its products. Medications and drug store items are generally considered essential and are not affected by economic fluctuations. Thus, over the five years to 2018, the industry has grown at an annualized rate of 3.4 percent, including an increase.

The report further shows that over the past five years, the Pharmacy & Drug Store Franchises industry has grown by 3.4 percent to reach revenue of $6bn in 2018. In the same timeframe, the number of businesses has grown by 1.3 percent and the number of employees has grown by 1.8 percent.

The bottom line is that the drug prescription delivery line of business is still very much open for new entrants; the competition within the industry is not as stiff as similar industries. If your business concept is top notch, you can gain fair share of the available market in any country or region you intend launching your business.

2. Executive Summary

Phoenix Pharmacy® Drug Prescription Delivery, LLC is a licensed pharmacy and drug store franchise that will be located in between a residential estate and a commercial avenue in Atlantic Avenue, Delray Beach – Florida. We have been able to secure a long-term lease agreement for a store cum warehouse facility in a strategic location with an option of long-term renewal on terms and conditions that are favorable to us.

Phoenix Pharmacy® Drug Prescription Delivery, LLC will engage in the retailing and delivery of a wide range of prescription drugs, medical products, therapeutic appliances and equipment et al. We are also in business to make profits at the same to give our customers value for their money.

We are aware that there are several retail pharmacy stores and drug prescription delivery companies scattered all around the United States, which is why we spent time and resources to conduct our feasibility studies and market survey so as to enable us locate the business in an area that can easily accept our Business model.

We ensured that our facility is easy to locate and we have mapped out plans to develop a far-reaching delivery network for our pharmaceutical products.

Phoenix Pharmacy® Drug Prescription Delivery, LLC will ensure that all our customers (individuals and hospitals) are given first class treatment whenever they order our products. We have a CRM software that will enable us manage a one on one relationship with our distributors no matter how large they are.

We will ensure that we get our customers involved when making some business decisions that will directly or indirectly affect them.

Phoenix Pharmacy® Drug Prescription Delivery, LLC is owned by Phoenix Josh. Phoenix Josh who is the Chief Executive Officer of the Company is Graduate of Pharmacy and she holds a Master’s Degree in Business Management (MBA) from Harvard.

She has over 14 years’ experience working in related industry as a senior sales manager prior to starting Phoenix Pharmacy® Drug Prescription Delivery, LLC.

3. Our Products and Services

Phoenix Pharmacy® Drug Prescription Delivery, LLC is going to run a standard and licensed drug prescription delivery company whose products will be delivered to customers in Atlantic Avenue, Delray Beach – Florida. We are in the pharmacy and drugs store franchise industry to make profits and also to give our customers value for their money. We will be engaged in;

• Generic drug prescriptions delivery services
• Brand-name drug prescriptions delivery services

4. Our Mission and Vision Statement

• Our vision is to establish a standard drug prescription delivery company with active presence in Atlantic Avenue, Delray Beach – Florida. We want to be amongst the leading brands in the pharmacy and drug store franchise industry.
• Our mission is to establish a standard and world class drug prescription delivery company/brand that in our own capacity will favorably compete with leaders in the industry. We want to build a business that will be listed amongst the top 5 drug prescription delivery brands in the United States of America.

Our Business Structure

Phoenix Pharmacy® Drug Prescription Delivery, LLC is established with the aim of competing favorably with other leading drug prescription delivery companies in the United States. This is why we will ensure that we put the right structures in place that will support the kind of growth that we have in mind.

We will ensure that we only hire people that are qualified, honest, hardworking, customer centric and are ready to work to help us build a prosperous business that will benefit all the stake holders. As a matter of fact, profit-sharing arrangement will be made available to all our senior management staff and it will be based on their performance for a period of five years or more depending how fast we meet our set target.

In view of that, we have decided to hire qualified and competent hands to occupy the following positions that will be made available at Phoenix Pharmacy® Drug Prescription Delivery, LLC;

• Chief Executive Officer (Owner)
• Pharmacist/Drugs Dispenser (Store Manager)
• Human Resources and Amin Manager

Merchandize Manager

Sales and Marketing Manager

• Accountants/Cashiers
• Customer Services Executive
• Drivers/Distributors

5. Job Roles and Responsibilities

Chief Executive Officer – CEO:

• Increases management’s effectiveness by recruiting, selecting, orienting, training, coaching, counseling, and disciplining managers; communicating values, strategies, and objectives; assigning accountabilities; planning, monitoring, and appraising job results
• Creates, communicates, and implements the organization’s vision, mission, and overall direction – i.e. leading the development and implementation of the overall organization’s strategy.
• Responsible for fixing prices and signing business deals
• Responsible for providing direction for the business
• Responsible for signing checks and documents on behalf of the company
• Evaluates the success of the organization

Admin and HR Manager

• Responsible for overseeing the smooth running of HR and administrative tasks for the organization
• Maintains office supplies by checking stocks; placing and expediting orders; evaluating new products.
• Defines job positions for recruitment and managing interviewing process
• Carries out induction for new team members
• Responsible for training, evaluation and assessment of employees
• Responsible for arranging travel, meetings and appointments
• Oversees the smooth running of the daily office activities.

Pharmacist/Drug Dispenser (Store Manager):

• Accountable for processing prescriptions and dispensing medication
• Answerable for ordering, selling and controlling medicines and other stock
• Responsible for meeting medical representatives
• Responsible for organizing the safe and efficient receipt, storage and dispatch of warehoused goods
• In charge of coordinating the use of automated and computerized systems where necessary for the distribution of drugs
• Responsible for keeping stock control systems up to date and making sure inventories are accurate;
• Responsible for producing regular reports and statistics on a daily, weekly and monthly basis
• Ensures that proper records of goods are kept and warehouse does not run out of products
• Ensure that the store facility is in tip top shape and goods are properly arranged and easy to locate
• Supervises the workforce in the store floor.
• Manages vendor relations, market visits, and the ongoing education and development of the organizations’ buying teams
• Responsible for the purchase of prescription medicine, medical products, therapeutic appliances and equipment for the organizations
• Responsible for planning sales, monitoring inventory, selecting the merchandise, and writing and pricing orders to vendors
• Manages external research and coordinate all the internal sources of information to retain the organizations’ best customers and attract new ones
• Models demographic information and analyze the volumes of transactional data generated by customer purchases
• Identifies, prioritizes, and reaches out to new partners, and business opportunities et al
• Documents all customer contact and information
• Represents the company in strategic meetings
• Helps to increase sales and growth for the company

Accountant/Cashier:

• Responsible for preparing financial reports, budgets, and financial statements for the organization
• Provides managements with financial analyses, development budgets, and accounting reports
• Responsible for financial forecasting and risks analysis.
• Performs cash management, general ledger accounting, and financial reporting
• Responsible for developing and managing financial systems and policies
• Responsible for administering payrolls
• Ensures compliance with taxation legislation
• Handles all financial transactions for the organization
• Serves as internal auditor for the organization

Client Service Executive

• Ensures that all contacts with clients (e-mail, walk-In center, SMS or phone) provides the client with a personalized customer service experience of the highest level
• Through interaction with customers on the phone, uses every opportunity to build client’s interest in the company’s products and services
• Manages administrative duties assigned by the human resources and admin manager in an effective and timely manner
• Consistently stays abreast of any new information on the organizations’ products, promotional campaigns etc. to ensure accurate and helpful information is supplied to customers when they make enquiries

Distribution Truck Drivers

• Assists in loading and unloading prescription medicine, medical products, therapeutic appliances and equipment
• Maintains a logbook of their driving activities to ensure compliance with federal regulations governing the rest and work periods for operators.
• Keeps a record of vehicle inspections and make sure the truck is equipped with safety equipment
• Assists the transport and logistics manager in planning their route according to a distribution schedule.
• Inspects vehicles for mechanical items and safety issues and perform preventative maintenance
• Complies with truck driving rules and regulations (size, weight, route designations, parking, break periods etc.) as well as with company policies and procedures
• Collects delivery instructions
• Reports defects, accidents or violations

6. SWOT Analysis

We are quite aware that there are several drug prescription delivery companies in the United States of America which is why we are following the due process of establishing a business so as to compete favorable with them. We know that if a proper SWOT analysis is conducted for our business, we will be able to position our business to maximize our strength, leverage on the opportunities that will be available to us, mitigate our risks and be welled equipped to confront our threats.

Phoenix Pharmacy® Drug Prescription Delivery, LLC employed the services of an expert HR and Business Analyst with bias in startup businesses to help us conduct a thorough SWOT analysis and to help us create a business model that will help us achieve our business goals and objectives. This is the summary of the SWOT analysis that was conducted for Phoenix Pharmacy® Drug Prescription Delivery, LLC;

Part of what is going to count as positive for Phoenix Pharmacy® Drug Prescription Delivery, LLC is the vast experience of our management team, we have people on board who understand how to grow business from the scratch to becoming a national phenomenon. So also, the wide varieties of pharmaceutical products that we sell, our large national distribution network and of course our excellent customer service culture will definitely count as a strong strength for the business.

A major weakness that may count against us is the fact that we are a new drug prescription delivery company in the United States and we don’t have the financial capacity to engage in the kind of publicity that we intend giving the business and also to leverage on economies of scale.

• Opportunities:

The opportunities available to drug prescription delivery companies with a wide range of drugs are enormous. This is due to the fact that almost all Americans take drugs for different reasons. Demand for medical devices used in elderly care has increased and is expected to continue rising.

Demand for medical supplies has increased as a result of the rising age of the US population and of course the changing demographics in the US population will have a favorable effect on the medical supplies sector. We were able to conduct a thorough market survey and feasibility studies so as to position our business to take advantage of the existing market for prescription drugs and also to create our own new market.

We are quite aware that just like any other business, one of the major threats that we are likely going to face are economic downturn and unfavorable government policies especially as it relates to prescription drugs. Another threat that may likely confront us is the arrival of a new drug prescription delivery company in same location where ours is located.

7. MARKET ANALYSIS

• Market Trends

A close study of the trends in the pharmacy and drug store franchise industry shows that the industry is expanding rapidly due to the demand for industry’s products by the aging population. So also, with the regulatory provisions of the Patient Protection and Affordable Care Act expanded consumer access to prescription insurance and provided increased opportunities for product development.

Going forward, the industry revenue growth is expected to outpaced revenue growth for the Brand Name Pharmaceutical manufacturing industry.

A large number of brand name drug manufacturers lost patent protection for blockbuster drugs beginning in 2010; demand for generics subsequently grew, as consumers demanded affordable versions of these high-profile products. These trends are expected to continue in the next five years.

As a matter of fact, private health insurance coverage typically lowers the price of pharmaceutical products by reducing individuals’ out-of-pocket health expenditures.

As private health insurance coverage increases, more individuals will be able to afford their medications; however, managed-care organizations may place downward pricing pressure on drug reimbursement rates, which could cut into industry revenue. The number of people with private health insurance is expected to decrease in 2018, posing a potential threat to the industry.

To sum it up, as the population ages, demand for pharmaceutical products that address the health ailments of the elderly typically rises. The industry benefits immensely from a rise in demand of prescription from this demographic. The number of adults aged 65 and older is anticipated to rise in 2018, representing a potential opportunity for the industry.

8. Our Target Market

When it comes to selling prescription drugs or even pharmaceutical products in general, there is indeed a wide range of available customers. In essence, our target market can’t be restricted to just individual clients but also hospitals, sick bay and other medical facility within our target market location.

We are in business to engage in marketing and distributing generic drugs and medical equipment. Hence our target markets are;

• Hospitals/Medical clinics
• Doctors and other specialist medical practitioners.

Our competitive advantage

A close study of the pharmacy and drug store franchise industry reveals that the market has become much more intensely competitive over the last decade. As a matter of fact, you have to be highly creative, customer centric and proactive if you must survive in this industry.

We are aware of the stiff competition and we are prepared to compete favorably with other drug prescription delivery companies. Phoenix Pharmacy® Drug Prescription Delivery, LLC is launching a standard drug prescription delivery company that will indeed become the preferred choice in Atlantic Avenue, Delray Beach – Florida.

Having links with suppliers, a clear market position and access to the latest and most efficient technology are part of what is going to count as competitive advantage for us. We are not ignoring the vast experience of our management team, we have people that understand how to grow business from the scratch to success.

So also, the wide varieties of brand name and generic prescription drugs and medical equipment that we distribute, our large and far reaching distribution network and of course our excellent customer service culture will definitely count as a strong strength for our business.

Lastly, our employees will be well taken care of, and their welfare package will be among the best within our category in the pharmacy and drug store franchise industry, meaning that they will be more than willing to build the business with us and help deliver our set goals and achieve all our aims and objectives. We will also give good working conditions and commissions to freelance sales agents that we will recruit from time to time.

9. SALES AND MARKETING STRATEGY

• Sources of Income

Phoenix Pharmacy® Drug Prescription Delivery, LLC is established with the aim of maximizing profits in the pharmacy and drug store franchise industry in the United States of America and we are going to ensure that we do all it takes to sell a wide range of brand name and generic drugs and medical equipment to a wide range of customers. Phoenix Pharmacy® Drug Prescription Delivery, LLC will generate income by engaging in;

• Pharmaceutical wholesaling
• Medical goods wholesaling

10. Sales Forecast

One thing is assured when it comes to drug prescription delivery company, if your pharmacy store is centrally positioned and easily accessible, you will always attract customers cum sales.

We are well positioned to take on the available market in Atlantic Avenue, Delray Beach – Florida and we are quite optimistic that we will meet our set target of generating enough income/profits from the first six months of operation and grow the business and our clientele base.

We have been able to examine the pharmacy and drug store franchise industry, we have analyzed our chances in the industry and we have been able to come up with the following sales forecast.

Below is the sales projection for Phoenix Pharmacy® Drug Prescription Delivery, LLC, it is based on the location of our business and other factors as it relates to small scale and medium scale drug prescription delivery company startups in the United States;

• First Fiscal Year: $250,000
• Second Fiscal Year: $390,000
• Third Fiscal Year: $650,000

N.B : This projection was done based on what is obtainable in the industry and with the assumption that there won’t be any major economic meltdown and there won’t be any major competitor delivering same prescription drugs as we do within same location. Please note that the above projection might be lower and at the same time it might be higher.

• Marketing Strategy and Sales Strategy

Before choosing a location to launch Phoenix Pharmacy® Drug Prescription Delivery, LLC and also the kind of prescription drugs we will deliver, we conduct a thorough market survey and feasibility studies in order for us to penetrate the available market in our target market location. We have detailed information and data that we were able to utilize to structure our business to attract the number of customers we want to attract per time.

We hired experts who have good understanding of the pharmacy and drug store franchise industry to help us develop marketing strategies that will help us achieve our business goal of winning a larger percentage of the available market in Atlantic Avenue, Delray Beach – Florida.

In summary, Phoenix Pharmacy® Drug Prescription Delivery, LLC will adopt the following sales and marketing approach to sell and deliver our prescription drugs;

• Introduce our drug prescription delivery company by sending introductory letters to hospitals, residents, schools and other key stakeholders in Atlantic Avenue, Delray Beach – Florida
• Advertise our products in community based newspapers, local TV and radio stations
• List our business and products on yellow pages’ ads (local directories)
• Leverage on the internet to promote our drug prescription delivery company
• Engage in direct marketing and sales
• Encourage the use of Word of mouth marketing (referrals)

11. Publicity and Advertising Strategy

Despite of the fact that our drug prescription delivery company is a standard one with a wide range of brand name and generic prescription drugs. We will still go ahead to intensify publicity for all our products and brand.

Phoenix Pharmacy® Drug Prescription Delivery, LLC has a long-term plan of distributing our brand name and generic prescription drugs in various locations all around the United States of America which is why we will deliberately build our brand to be well accepted first in Atlantic Avenue, Delray Beach – Florida before venturing out.

Here are the platforms we intend leveraging on to promote Phoenix Pharmacy® Drug Prescription Delivery, LLC;

• Place adverts on both print (community based newspapers and magazines) and electronic media platforms
• Sponsor relevant community programs
• Leverage on the internet and social media platforms like; Instagram, Facebook, twitter, et al to promote our generic pharmaceutical product brand
• Install our billboards in strategic locations all around Atlantic Avenue, Delray Beach – Florida and in major cities in the United States of America
• Distribute our fliers and handbills in target areas
• Position our Flexi Banners at strategic positions in the location where we intend getting customers to start patronizing our products.
• Ensure that our products are well branded, all our staff members wear our customized clothes, and all our official cars and distribution vans are customized.

12. Our Pricing Strategy

When it comes to pricing model of drugs, in the United States there are many resources available to patients to lower the costs of medication. These include copayments, coinsurance and deductibles. The Medicaid Drug Rebate Program is another example.

Generic drug program lowers amount of money a patient has to pay when picking up their prescription at the pharmacy and as their name implies they only cover generic drugs. Co-pay assistance programs help patient lower costs of specialty medications: i.e. medications that are on restricted formulary, limited distribution, and with no generics available.

Patient assistance programs are funded by the manufacturer of the medication. Patients can often apply to these programs through the manufacturer’s website. This type of assistance program is one of the few options for the uninsured patient.

The out of pocket costs for patients enrolled in co-pay assistance or patient assistance programs are $0. It is a major resource to help lower costs of medications – however, many providers and patients are not aware of these resources.

In view of that, our prices will conform to what is obtainable in the industry but will ensure that within the first 6 to 12 months our brand name and generic prescription drugs are deliver a little bit below the average price in the United States of America. We have put in place business strategies that will help us run on low profits for a period of 6 months; it is a way of encouraging people to buy into our brand.

• Payment Options

The payment policy adopted by Phoenix Pharmacy® Drug Prescription Delivery, LLC is all inclusive because we are quite aware that different customers prefer different payment options as it suits them but at the same time, we will ensure that we abide by the financial rules and regulation of the United States of America.

Here are the payment options that Phoenix Pharmacy® Drug Prescription Delivery, LLC will make available to her clients;

• Payment with cash
• Payment via credit cards
• Payment via online bank transfer
• Payment via check
• Payment via mobile money transfer

In view of the above, we have chosen banking platforms that will enable our client make payment for brand name and generic prescription drugs purchase without any stress on their part. Our bank account numbers will be made available on our website and promotional materials.

13. Startup Expenditure (Budget)

If you are looking towards starting a drug prescription delivery company, then you should be ready to raise enough capital to cover some of the basic expenditures that you are going to incur. The truth is that starting this type of business does not come cheap.

You need money to secure a standard store or warehouse facility, acquire brand name and generic prescription drug supplies and distribution vans and you need money to pay your workforce and pay bills for a while until the revenue you generate from the business becomes enough to pay them.

The items listed below are the basics we will need when starting our drug prescription delivery company in the United States, although costs might vary slightly;

• The total fee for registering the Business in the United States of America – $750.
• Legal expenses for obtaining licenses and permits as well as the accounting services (software, P.O.S machines and other software) – $1,300.
• Marketing promotion expenses for the grand opening of Phoenix Pharmacy® Drug Prescription Delivery, LLC in the amount of $3,500 and as well as flyer printing (2,000 flyers at $0.04 per copy) for the total amount of – $3,580.
• The cost for hiring Business Consultant – $2,500.
• The cost for insurance (general liability, workers’ compensation and property casualty) coverage at a total premium – $2,400.
• The cost for payment of rent for 12 months at $1.76 per square feet in the total amount of $55,150.
• Other start-up expenses including stationery ($500) and phone and utility deposits ( $2,500 ).
• Operational cost for the first 3 months (salaries of employees, payments of bills et al) – $50,000
• The cost for start-up inventory (purchase of wide varieties of brand name and generic prescription drugs meant for distribution) – $100,000
• The cost for store equipment (cash register, security, ventilation, signage) – $13,750
• The cost of purchase of distribution vans – $60,000
• The cost for the purchase of furniture and gadgets (Computers, Printers, Telephone, Fax Machines, tables and chairs et al) – $4,000.
• The cost of launching a website – $600
• Miscellaneous – $10,000

We would need an estimate of five hundred thousand dollars ( $500,000 ) to successfully set up our drug prescription delivery company in Atlantic Avenue, Delray Beach – Florida.

Generating Funds/Startup Capital for Phoenix Pharmacy® Drug Prescription Delivery, LLC

Phoenix Pharmacy® Drug Prescription Delivery, LLC is owned and financed by Phoenix Josh. She has decided to restrict the sourcing of the startup capital to 3 major sources.

• Generate part of the startup capital from personal savings and sell of stocks
• Source for soft loans from family members and friends
• Apply for loan from my bank

N.B: We have been able to generate about $100,000 ( Personal savings $80,000 and soft loan from family members $20,000 ) and we are at the final stages of obtaining a loan facility of $200,000 from our bank. All the papers and documents have been signed and submitted, the loan has been approved and any moment from now our account will be credited with the amount.

14. Sustainability and Expansion Strategy

The future of any business lies in the number of loyal customers that they have, the capacity and competence of their employees, their investment strategy and the business structure. If all of these factors are missing from a business, then it won’t be too long before the business closes shop.

One of our major goals of starting Phoenix Pharmacy® Drug Prescription Delivery, LLC is to build a business that will survive off its own cash flow without the need for injecting finance from external sources once the business is officially running.

We know that one of the ways of gaining approval and winning customers over is to sell our prescription drugs a little bit cheaper than what is obtainable in the market and we are prepared to survive on lower profit margin for a while.

Phoenix Pharmacy® Drug Prescription Delivery, LLC will make sure that the right foundation, structures and processes are put in place to ensure that our staff welfare are well taken of. Our company’s corporate culture is designed to drive our business to greater heights and training and retraining of our workforce is at the top burner.

We know that if that is put in place, we will be able to successfully hire and retain the best hands we can get in the industry; they will be more committed to help us build the business of our dreams.

Check List/Milestone

• Business Name Availability Check : Completed
• Business Registration: Completed
• Opening of Corporate Bank Accounts: Completed
• Securing Point of Sales (POS) Machines: Completed
• Opening Mobile Money Accounts: Completed
• Opening Online Payment Platforms: Completed
• Application and Obtaining Tax Payer’s ID: In Progress
• Application for business license and permit: Completed
• Purchase of Insurance for the Business: Completed
• Leasing of facility and construction of standard store facility / warehouse: In Progress
• Conducting Feasibility Studies: Completed
• Generating capital from family members and friends: Completed
• Applications for Loan from the bank: In Progress
• Writing of Business Plan: Completed
• Drafting of Employee’s Handbook: Completed
• Drafting of Contract Documents and other relevant Legal Documents: In Progress
• Design of the Company’s Logo: Completed
• Printing of Promotional Materials: In Progress
• Recruitment of employees: In Progress
• Purchase of the needed furniture, racks, shelves, computers, electronic appliances, office appliances and CCTV: In progress
• Creating Official Website for the Company: In Progress
• Creating Awareness for the business both online and around the community: In Progress
• Health and Safety and Fire Safety Arrangement (License): Secured
• Establishing business relationship with vendors – households, hospitals, and schools et al: In Progress

Related Posts:

• Retail Pharmacy Business Plan [Sample Template]
• Pharmaceutical Distribution Business Plan [Sample Template]
• How to Start a Pharmacy Business
• How Much Does a Specialty Pharmacy Make Yearly? [Profit Margin]
• How Do You Get Pharmacy Tech Certification as a Felon?

Tips to Start a Pharma Distribution Business

• 142 comments
• 5 expert advice
• 55,701 views

The wholesaler link in the drug distribution chain is pharmaceutical distribution. Pharmaceutical distribution businesses are the ones that purchase medicines from big suppliers such as Merck and Pfizer, then put them to warehouses and distribute them to many pharmacies out there.

• Google Share

Now, if you are planning in opening a pharma distribution business, there are factors for you to think about such as your target market, business plan, great venture, employees, and many others.

Create a business plan. You have to put your outline, your financial info, your financial resources, your marketing strategy, your perspective location, how to set up a website, your business legal structure, number of employees, and so on.  

Think about your target market, and then pick the perfect location for your business. You can come up with few options, check each of your options and choose the best location wherein it is accessible to streets and highways and where your targeted markets can easily find you.  

Get the insurance, licenses, and permits. Hire employees that you need for your pharma business. You have to hire ones that are knowledgeable with meds and can be keys to your business success. Advertise your business. There are lots of ways to advertise your business. You can try the ones that are cheap ways to do it. Setting up a website is one of the great ways to advertise your business. There is a way to do it without spending a fortune on it. Just do your research.  

Putting up a marketing campaign is a good way to make your pharma distribution business grow. From your perspective market knows more about your business and what you offer, you have to work as your own PR manager. You can make use of social media sites such as Facebook and Twitter. There are millions of individuals who are making use of these sites and participating in the games that these sites entail you.  

You need to calculate the business gross margin. You’ll be able to determine the efficiency of your business by looking through the costs and understanding the cost of goods sold. You have to see to it that you increase the profit margins, you can do this by purchasing in bulk, having a long-term contract with a supplier for lower cost, and so on.  

You have to do your research regarding your competitors. You have to find what people are telling about them and how they build up their own business. In doing this, you can compare what you have and what you can offer from what they offer. It can be a help to your business if you try your best to be ahead of them. These are few factors that you need to take into account when opening a pharma distribution business .

142 Comments

• Bikash Rana   said on February 25, 2013 Dear Sir/Mam, I am keen to operate distributionship of pharma products in Siliguri, West Bengal. I have gone through your website and I found it very informative. Furthermore I would like to understand the future prospect of operating distributionship in this region. I will remain at your disposal. Kind Regards, Bikash Rana
• Niraj Kumar   said on March 11, 2013 I want to start medicine distribution business. Muzaffarpur, Bihar
• gen   said on April 10, 2013 Hi there, I am really interested in owning my own distribution company because currently I am connected with a pharmaceutical. Would want to hear more to where I could scout products that are saleable and would have good movement in the market. Currently I have a list of a few products but the problem is I don't know where to start to get them at a very good price to have higher income margin. Hope to hear from you. Cheers.
• j.nagaraja   said on May 10, 2013 i am very much interested in starting a new medical distribution agency, i had an experience of one year as a medical representative .could you plz help me to start.
• banarsi das gupta   said on May 15, 2013 I am starting my veterinary pharma company, in North India. wants to recruit sales staff from top to bottom.
• rakesh prajapati   said on May 27, 2013 I want to start marketing of pharmaceutical products in gujarat with contract manufacturing. What are the requirements plz suggest me. Thanks
• vishal upadhyay   said on May 29, 2013 i am a pharmacist, presently working in a US based retail pharmacy, earlier worked in Apollo pharmacy as an executive, have a overview of the pharma retail and distribution. the question is how to get started with my own distribution unit. staying in mumbai suburbs.
• luke smith   said on June 6, 2013 I looking for a oversees distributor to import here in U.S.
• emmanuel   said on June 8, 2013 i am very much in interested in the pharma distribution space kindly help through the details of how to approach the supplier and the initial investment required
• Neelesh Kumar Yadav   said on July 7, 2013 Dear sir/Madam, I am from bhilai chattisgarh. I too want to start a pharmaceutical business. Some one give me the clue for a very small scale, as i am poor with no money. As i earn, i would like to set up a business. very small one which can be affordable by me. kindly give me a simple layout? business location raipur, bhilai and bilaspur
• SANJAY   said on July 24, 2013 HI, I am very much keen to start the pharma distribution in lucknow/ delhi. i am having the educational background of B.PHARMA as well. Please help me in guiding to take over the business. waiting eagerly for your response.
• M.Raheel   said on August 18, 2013 SIR/Madam i'm much interested to start the pharmaceutical distribution business. But on the other hand i have limited resources. But the + point is i'm related to pharmaceutical. These are good advises But i want to more information related to distribution business.
• George motes   said on August 22, 2013 Johannesburg, South Africa. Would like to venture into the neighboring countries as well eg Zimbabwe, Zambia, Botswana, Swaziland, Lesotho, Mauritius, Walawi, Mozambique, Namibia
• aditya boruah   said on August 25, 2013 Dear sir/madam. i am 4rm guwahati assam. i am very much interested in pharma distribution business. kindly help through the details of how to approach the supplier & the initial investment required. i want to know everything about it accept paper works.
• manoj burkule   said on October 19, 2013 I want to start pharma distribution down kalyan, thana, mumbai. I want to know the requirement for start As semi distributor & legal procedure for the same.
• Satyam Kumar   said on November 10, 2013 Hello Sir/ or Madam, This is Satyam Kumar from Patna, willing to have Pharma distribution company. kindly provide me the details of Pharmaceutical distribution business, how can i succeed in this. Also tell how much money do i need to invest, however i want to start from low budget. I am looking forward to hear from you. Thank you
• MURIGEPPA JAVALI   said on November 22, 2013 Dear sir, i want to start pharma distribution in Hubli, Karnataka, please provide me required necessaries like drug license, Tin No, labour license and bank current ac opening details, and i want to start investing low budget and i am looking forward to here from you. Thank you.
• Sandra   said on December 31, 2013 I want to start a pharma distribution company in the USA, what companies would I contact for contracts ? and would it be best to seek an overseas medical distributor to purchase from ? Are there companies I can contact for sample products ? Will I only require a regular business license ? or something special to distribute medication ?
• Sanjay   said on January 25, 2014 I need a business plan/project for pharmaceuticals sales in Delhi please help me out preparing this as I have to take loan for this.
• Prashant Gurjar   said on March 4, 2014 Hi, i stay in mumbai and i am looking forward to start a pharmacy distribution centre in south mumbai. i would want to know what kind of license i will require, how do i approach pharma co? how will i get it going? what will be the overall investment? and what would be my ROI? thanx n regards, Prashant Gurjar
• manas subudhi   said on March 12, 2014 Dear Sir, I want to start the pharma distributorship business in bhubaneswar of leading pharma company, can you guide me whome to contact ? Secondly is it good to take pcd franchise of non leading companies of india? i have 3 years experience in medicine representative experience and i was previously working in mumbai long back, now i want to start the distributorship in bhubaneswar(orissa)
• ASISHDEV   said on March 19, 2014 Planning to start wholesale firm at bhubaneswar, odisha. Please provide necessary tips on it. Thanks and regards.
• siddharth sethi   said on March 20, 2014 I would like to start distribution business in delhi as consignee agent or c&F , Kindly guide on the matter
• Shailendra   said on March 31, 2014 We are starting as a C&F and wholesale distribution in Rajasthan and looking for young and motivated persons to grow with us. Shailendra
• peter joyce   said on April 17, 2014 hi i'm wanting to start a wholesale, distribution business in pharmaceuticals sales based in the UK can you help
• RAVI RATNANI   said on April 18, 2014 HI I AM FROM CENTRAL DELHI DISTRIBUTOR IN DELHI I WANT TO ADD SOME MORE COMPANIES HOW CAN I APPLY ONLINE MORE BIG COMPANIES FOR DISTRIBUTIONSHIP IN DELHI??
• Chirag   said on May 10, 2014 Our client wants to sale 50 years running pharma bulk drug distribution business in Mumbai. Company is a member of bulk drug association in mumbai that typically restricts the number of firms that can operate in the drug distribution business. Thus it is very difficult for a new entrant to break into this business. Company purchases drugs from various pharma companies (Company is agents to about 10 large pharma companies in India) and sells them over South Mumbai. Clients range from small retail chemists to large hospitals and even semi-wholesalers who buy in bulk and sell in the retail markets. Recent annual turnover was INR 10 crores. The opportunity for the buyer would be to get an entry into a fast growing and stable healthcare segment in India, expand territories (expand to other parts of India) and potentially even use Mumbai as a base to export drugs to international markets. Also there is a good opportunity to increase the sales which was presently not done on account of lack of resources. Only seriously interested parties can contact on [email protected]
• ousmael   said on May 14, 2014 I am starting to establish a distributor company for Pharmaceuticals in Addis Ababa, Ethiopia. Please send me factors to consider.
• Manish Kumar   said on May 24, 2014 Hello friends. We r looking for C&f, distributor, dealers (District wise) for one of the emerging company with almost 25 products in all segment, we r currently looking for Bihar, Jharkhand, UP, and interested. If interested, send me mail on my Email id: [email protected]. Mo. 09685495245
• Vivek chauhan   said on May 26, 2014 Hi, How get it medicine Distributor Ship in Dwarka Delhi .can u help me anybody plz 9717014232
• vishak   said on June 7, 2014 sir.. Currently I own a medical shop, and I would like to expand my business by setting up a pharmaceutical wholesale distribution company. So i am really interested in knowing the current whereabouts like , how financially capable should I be, how much could possibly be the minimum profit, how big is the market. Please respond to this with all the details.
• prashant kumar   said on July 7, 2014 I want to start a pharma company
• sagar   said on July 14, 2014 sir i leaving in Solapur city .state of Maharashtra . i started business of Pharma wholesale. i am b com graduated. i have work experience in pharma line . i working in multinational company job role of medical representative. plz guidance .
• Girish Patel   said on July 19, 2014 SIR I AM FROM MUMBAI I WANT TO START PHARMA DISTRIBUTORSHIP WITH PARTNER WHO KNOWS ABOUT PHARMA BUSINESS
• MR C   said on July 29, 2014 Hello Everyone, I am in the market to either partner or purchase a pharmaceutical company for a specialized market here in the USA. Please forward me any information as to perspective businesses that would fit either of these categories. Thank you for your time and consideration. I wish you all wealth and good health. Sincerely, Mr. C [email protected]
• Maria Girlie Maghanoy-Ledesma R.N.,D.M.D.   said on September 4, 2014 I am currently running a Little business in Iligan City, Philippines under DTI business name Galera de Vahnazka (Tooth, Nails, Beauty and Tummy) part of it (convenient store is a little drug store)May I have some guides on how to put up a pharmaceutical distributorship/exclusive distributor of medicines. Thank you
• farmini   said on September 7, 2014 Hi there, my name is George and I am running a wholesale distributor company in Greece , specialized in Selling OTC pharmaceutical products to pharmacies...I have an experience teem of reps and I am looking for companies all over the world to be their dealer .. I am looking for unique, quality products .. Is there a link or something I can look at? Thank you.
• ASHIM PAL   said on September 12, 2014 I am ASHIM PAL having 12+ years working knowledge of medicine distributor & retails counter. Now I want my own distributorship business for Medicine but my initial investment should be Rs.50000.Can you give idea for small investment and my location is Kolkata,Westbengal. Pls help me .
• kumar abhinay   said on September 13, 2014 hi, i am abhinay , taking care of my pharma business for last five years in bihar, looking to expand my business in unrepresented area and contact me on my cell no,9931439430
• Dinesh kumar   said on September 15, 2014 Sir, I have a completed b.pharma and I have a choice start drug importing and exporting so plz contact 8871325016 and provide information
• Devesh   said on October 11, 2014 I want to establish my own pharma products distribution company in Ahmedabad. Pls advice me how to start, what all Govt. documents require in Ahmedaba? How can i start business, sale and increase business. Areas of distribution of drus? Thanks & Regards, Devesh Mob #7802074424
• amol gunjal   said on October 27, 2014 I am starting a wholesale ...so plz guide me
• Pankaj Uniyal   said on November 1, 2014 I want to start pharma distributorship in Dehradun. pl. inform me all essentials for this business.
• Arnold Fernandes   said on November 19, 2014 Mumbai Maharashtra India. What are the licenses required to start an online Pharma company in Mumbai
• Gaurang shah   said on December 6, 2014 I want to start the pharmacy distribution in jamnagar Gujarat. Plz guide me necessary information.....
• Sateesh   said on December 23, 2014 I want to start medical distribution business in srikakulam district in Andhra pradesh. Guide me how much minimum investment required for the proper running of business in initial years.
• naresh   said on December 27, 2014 we are a leading pharma company (chandigarh based). have a wide range of pharma products in all segments. call for pharma franchisee all over india.. contact-09216222760 or mail- [email protected]
• Faisal   said on January 3, 2015 I want to start a pharma distribution in Brisbane please advise. Anyone interested in business partner with me please advise. or sell there product or market there product please advise. [email protected]
• naresh   said on January 5, 2015 contact for pharma franchisee all over india with dpco free products in all major segments.
• Rukhsana Mudassir   said on January 10, 2015 I Rukhsana Mudassir running my pharma business ((ABM Pharma) for 12 years with self manufacturing. Contact for pharma franchise all over Pakistan.
• upendra   said on January 11, 2015 Dear sir/Madam, I want to start pharma whole sale business. Presently i am working in pharmaceutical company so may be i could start this business in Andhrapradesh. But I m from non pharma back ground. Please suggest me how start my business. What are the licenses are required or qualification/requirements for starting of my business. Please advise me, [email protected]
• manish kansara   said on January 19, 2015 I want to start my own wholesale pharma business. I completed my D.pharma and I did pharma marketing. now I want to start my own business. I want info regards how much finance is necessary and which license are required. pls mail me its urgent. Thanking you
• usman farooq   said on February 4, 2015 hello dears i'm from Pakistan and looking for a medicines distribution company, i am a business graduate and have no idea of pharma so it is a kind request to plz give some tips and advices to start my business. plz share business related material in my mail box, usmanx100"hotmail.com. thanks best regards usman
• Anuj Gupta   said on February 12, 2015 Hello, I anuj gupta want to start medicine distribution company in sector 22, rohini, delhi. Kindly share or advice me how i setup my new business.
• Prahlad Singh   said on February 18, 2015 hello, I am prahlad singh i have 7 years of pharma sales and marketing experience wanted to start pharma marketing company with third party manufacturing kindly suggest the process involved currently Based at haldwani uttrakhand
• Ganesh Chiliveri   said on March 3, 2015 Dear Sir, I am working with Pharma company but my education is not at all related to science ( education is from Commerce ). I would like start self employment in pharma distribution ship. Hence guide me, whether pharma education background is necessary.
• raja   said on March 10, 2015 Dear sir. I would to start a. Distributor in pharmaceutical. In chennai.still i dont have an idea where to start.can you help me.also what is license require. What is c&d in distributor's.please reply soon.
• meghana   said on March 22, 2015 I want to start distributor business in pharmaceutical. I don't have any idea how to start. please guide me.
• Indranil Ray   said on March 23, 2015 I want to start a drug distribution business.. please guide me.. I am from Guwahati, Assam, India.
• Badal Raut   said on March 25, 2015 I am interested in the pharma business. I am currently located at mumbai, vile parle.
• Indrajeet yadav   said on April 6, 2015 I want to start pharmaceutical wholesale business in suriyawan bhadohi uttar pradesh kindly guide me about regarding business. Thanks & Regards, Indrajeet mob-8756967242
• Yogesh   said on April 10, 2015 Hello friends, we are manufacturer of pharmaceutical products and medicines and looking for pharmaceutical products distribution, retail markets and Marketing Representative. Please send us your detail ASAP on [email protected], [email protected]
• Yogesh Padwal   said on April 17, 2015 Hello friends I want to start my own distributorship business in pune my qualification is Bsc chemistri . SO can I get license for this on my qualification please suggest me kindly
• Yogesh Dalvi   said on April 18, 2015 I want to start pharma distributorship in rural area near Pune City, Maharashtra. want detail information.
• Ashvin   said on April 19, 2015 Hi friends. I live in mauritius and i am planning in creating my own distribution channel (wholesale) in pharmaceutical drugs. Please guys, do u know any pharmaceutical firms which want to expand in Mauritius. please contact me.
• RANJAN PATEL   said on May 8, 2015 dEAR @Ashwinji; We are in planning to mfg allopathy 25 products and want to market in moretius if possible so pl be a partner with us and help us to market our brands. m 09760315509 08735871513 [email protected]
• Sachin   said on May 16, 2015 want to start a distribution business at Dharwad, Karnataka.... So kindly help me out
• dr somanath mishra   said on May 21, 2015 Sir i am a ayurved doctor and my own medical store, but i want to start a c&f of medicine company at jeypore, orissa. So plz guide me.
• Sahil   said on June 5, 2015 Hi, I have done B Pharm and have total 8 years of experience in regulatory affairs. I want to start my own business in Gujarat Ahmedabad. Would you please guide me all necessary step and how to start and how much budget do I need? I will be more happy with partnership with anyone who already in business. I would really Appreciate your guidance. Many Thanks, Sahil [email protected]
• momammed   said on June 9, 2015 Hi Sir, I have done Master Degree in Biochemistry, looking for pharmaceutical distribution business in bangalore and chittoor Dist.places. kinldy assist me. contact no.9886059467.
• Sachin kumar   said on June 16, 2015 We have established a pharmaceuticals company with good qualities products, we expanding of own company to all over india and abroad, Please contact me who's interesting for franchise of our companies products on "[email protected]" Thank You.
• Rakesh   said on June 22, 2015 How much investment required to open a pharmaceutical distributor in bangalore?
• Dipta Karmakar   said on June 29, 2015 I want to start my career as Drug Distributor in Nadia District and my residence is at Dhubulia. Kindly guide me the procedure and future of this career. Thank You
• Mogomotsi Madziba   said on June 30, 2015 Hi! I am in Botswana and have an idea of starting a pharmaceutical distribution company. I need investors especially from abroad. The potential is huge. [email protected]
• Vinod Dingale   said on July 8, 2015 Hello Team, Planning to start a distribution business in Pharmacy. Need your help as I am new to this. What is the process of registration, from where will i get the forms, what will be the License fees, and the entire process. Awaiting for your reply. Regards, Vinod Dingale
• gopabandhu mallick   said on July 11, 2015 Hello, i am planning to startup a pharmaceutical distribution business in Cuttack. state odisha and looking for a global pharma company who invest and how much money needed for basic to startup.
• ali gohar   said on July 30, 2015 Want to start pharma distribution with niche healthcare products. please advise
• s.Malik   said on August 10, 2015 Sir. I am a bpharma with ten yrs of pharma retail and marketing exp now i like to start a wholesale business. pls guide me my budget is around ten lacs i am from tamil nadu 8056819515
• manish mishra   said on August 21, 2015 Sir, I am manish mishra with ten yrs of marketing exp now i like to start a small wholesale pharma business. pls guide me my budget is around five lacs i am from madhya pradesh . 7228000406
• Anand   said on August 21, 2015 Dear Sir, I want to start the pharma distributorship business in Varanasi (UP) of leading pharma company, can you guide me whom to contact ? i have 3 years experience in medicine representative experience and i was previously working in Delhi long back, now i want to start the distributorship in Varanasi (UP) mob. no. 9450937613
• Purushottam   said on August 31, 2015 Dear sir, I want to start pharma distributorship business in faridabad of leading phama company can u guide me or help me for this field ..my budget is about 10 lacs. my mob no is 9468299598. I am frm faridabad ....
• Dharam Ashar   said on September 6, 2015 What licenses are required to start pharma distribution business.
• Sebsibe Alemu   said on September 10, 2015 my name is sebsibe am pharmacist in ethiopia, east wollega ,nekemte i try to start my own business in wholesales try to help me in business plan
• golden   said on September 15, 2015 I am opening the pharmaceutical wholesale business but I need funds.
• Kartik Jain   said on September 17, 2015 I want to open pharmaceutical distribution business in Pune as I am young I want your guidance.
• Shauib mahmood   said on September 17, 2015 Hi i want to start a distribution business give me some tips am from maharashtra district ratnagiri. Town chiplun.
• Shuaib mahmood   said on September 17, 2015 Hi, I want to start a wholesale business of pharmacy in chiplun. Maharashtra district ratnagiri town chiplun. Can u suggest me some tips?
• Rajendra alwar   said on September 20, 2015 Dear sir I am based at Alwar Rajasthan and want to start medical supply business with small capital of 5-7 L.I want to know how to start d business, from where I can get the supply. If require I can invest more money.Please advice
• Yogesh   said on October 1, 2015 I would like to develop pharmaceutical distribution set up for NCR n Himachal.I have experience with Ranbaxy n 1 more pharmaceutical co.and my daughter is Dr.Thank
• santosh   said on October 12, 2015 I am santosh from mumbai wanted to start pharma distributors business mail me details on [email protected]
• Rod   said on October 16, 2015 Hi sir,i am just starting distributing medicines here in mindanao,philippines.I am just a freelancer.I want to register my small business.What are the requirements? Thnks
• Abhijeet khele   said on October 21, 2015 Hi sir,am thinking of starting pharma distribution business in nasik city(maharashtra state) please help me regarding process,licensing. My budget is 2-3lacs only.

[email protected] || Consultant

• apar   said on November 14, 2015 Sir i want to be a dealer or stockist of phrma company products in agra.Want to take agency.Please help me n tell what its process ,money need,and other formalities. Thnks n regard Apar l
• Ramanarayana   said on November 17, 2015 sir my b.pharm completed this year i have to start own wholesale shop.My native is Punganur, chittoor (dt),andra pradesh please suggest company to my shop distributed.
• abhishek jaikhedkar   said on November 24, 2015 I want wholesale distributorship of pharma companies in nashik how to take pharma companies distributorship.
• Raj Shekar   said on December 2, 2015 Dear Sir/Madam, I am keen to start a business in Pharma Distribution and I have no knowledge about these could you please guide me how to start of and where the get the information.
• Altaf Tramboo   said on December 4, 2015 Dear Team, Kindly advise how to start this business . I am from srinagar J&K and have space about 700 sft in prime location. Thanks
• Jason   said on December 29, 2015 Dear Team, We're looking forward to get into Online Pharmacy to cater to US, UK & Australia customers and wish to export med from India. We've a dedicated outbound sales team which is currently dialing for a client in US however we want to start up independently.We're eyeing to become a local distributor in Mumbai and similarly export med (drop ship) with help of Online Pharmacy Website and Outbound Tele calling team. Request anyone with knowledge to help us with details on how to set up this business and what are the legal requirement for the same. Feel free to contact me on [email protected]

[email protected] || Consultant

• Franchise Opportunities
• Wholesale Business Opportunities
• Small Manufacturing Business
• Farming Business Ideas
• Unique Business Opportunities
• Shop Business Ideas
• Small Business Opportunities
• 100 Business Ideas
• Cool Business Ideas
• Healthcare Business Ideas
• Home Delivery Business Ideas
• Low Cost Business Opportunities
• Milling Business Ideas
• Mobile Business Ideas
• Pet Business Ideas
• Popular Business Opportunities
• Smart Business Ideas
• Software Used in Business
• Sports Business Opportunities
• Wedding Business Ideas
• Startup Company Ideas
• Home Based Business Opportunity
• Rural Business Opportunities
• Tips for Buying and Selling
• Starting Rental Business
• Ideas for Small Business
• Free Business Ideas
• Internet Business Ideas
• Store Business Opportunities
• Entrepreneur Business Idea
• Retail Store Ideas
• Service Business Ideas
• Advice for Small Business
• Financing a Small Business
• Restaurant Business Opportunities
• Small Business Articles
• Business Marketing and Advertising
• Repair Business Opportunity
• Professional Career Opportunities
• Business Insurance Information
• Instructor Guides

Popular Articles

• How to Start a Non Emergency Medical Transportation Business
• How to Start a Medical Tourism Business
• How to Start a Medical Waste Disposal Business
• How to Start Medical Marijuana Business
• What is Private Healthcare
• How to Start a Private Duty Nursing Business
• How to Start a Nursing Agency?
• 5 Steps to Open a Geriatric Care Management Business
• Starting a Nursing Case Management Business
• 6 Key Points on Starting a Medical Screening Business

• Pharmaceutical Engineering Magazine
• Online Exclusives
• Special Reports
• Facilities & Equipment
• Information Systems
• Product Development
• Production Systems
• Quality Systems
• Regulatory Compliance
• Research + Development
• Supply Chain Management
• White Papers
• iSpeak Blog
• Editorial Calendar
• Article of the Year
• Submit an Article
• Editorial Team

Business Continuity Planning to Prevent Drug Shortages

As noted in the ISPE Drug Shortages Prevention Plan, 1 business continuity planning is a powerful, methodology, essential for enabling an uninterrupted supply of critical medicines for patients in challenging manufacturing circumstances. This “30,000-foot view” article shares an executive summary of principles and best practices of business continuity planning to ensure continued pharmaceutical supply.

• 1 International Society for Pharmaceutical Engineering. “ISPE Drug Shortages Prevention Plan: A Holistic View for Root Cause to Prevention.” October 2014. https://ispe.org/DrugShortagesPreventionPlan

While powerful, business continuity planning is not always leveraged optimally for preventing drug shortages because it can be difficult to initiate and maintain, particularly when future supply challenges may be unknown or unpredictable, and because it can require a significant investment of money, personnel, training, and other resources. However, over the lifespan of any company, unexpected challenges will inevitably surface. The COVID-19 pandemic is the most illustrative example of our times regarding how significant business continuity planning may be to ensuring uninterrupted supply of critical medicines, as the entire pharmaceutical industry has been challenged by both unprecedented demand and supply constraints globally.

It is understandable how immediate operations necessary to maintain routine supply to the market may be prioritized over proactive measures, which may never be needed or needed in the way that was originally anticipated. Yet it remains essential that pharmaceutical industry leaders pursue strategic approaches for business continuity planning because drug shortages may devastatingly impact patients and their families, as shown in the recent ISPE Drug Shortages Webinar, which described one pediatric cancer patient’s challenges from multiple drug shortages. 2

In recent years, large-scale events have motivated governments, health authorities, and patients to focus on the reasons behind supply disruptions. While many root causes are being explored, some markets are prioritizing business continuity planning for the prevention of drug shortages and making these plans a requirement in certain cases. 3 , 4  Any procedures established to meet these new requirements should be developed with sufficient flexibility to accommodate appropriate evolution of business continuity planning because the risks of today may not be the risks of tomorrow.

Approaches to Business Continuity Planning

The guidance presented in this article is intended to assist pharmaceutical leaders in striking the right balance between critical patient needs and the business investment for drug shortage prevention measures. In general, the concepts described herein apply to all types of pharmaceutical products, including active pharmaceutical ingredients (APIs), finished drugs, biologics, vaccines, medical devices, and combination products.

There are a number of excellent resources for business continuity planning. Notably, the ICH Guideline for Quality Risk Management Q9 5 serves as an important resource document for existing practices, standards, and guidelines within the pharmaceutical industry. As such, ICH Q9 concepts and terminology will be used throughout this overview.

At the outset of pursuing robust business continuity planning for preventing drug shortages, it is important to recognize this is not a one-time event. Rather, the four primary activities in business continuity planning—establishing product priority, evaluating risk to supply, developing mitigation options and agility strategy, and implementing response plans—will need to be revisited and adjusted as the product portfolio and business dynamics change over time (Figure 1). Therefore, companies should develop programs to support an ongoing refresh of their business continuity plans.

• 2 International Society for Pharmaceutical Engineering. “Resolving and Avoiding Drug Shortages and the Health Crises They Create” (webinar). 1 September 2020. https://ispe.org/webinars/video/resolving-avoiding-drug-shortages-health-crises-they-create-webinar>
• 3 Garnier, Y. “The French System for Preventing and Managing Shortages.” BlueReg Pharma Consulting. 28 May 2020. https://blue-reg.com/the-french-system-for-preventing-and-managing-shortages
• 4 Covington & Burling LLP. “CARES Act Reforms Aim to Prevent Shortages of Critical Medical Products.” 5 April 2020. https://www.cov.com/-/media/files/corporate/publications/2020/04/cares-act-reforms-aim-to-prevent-shortages-of-critical-medical-products.pdf
• 5 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. “ICH Harmonised Tripartite Guideline: Quality Risk Management Q9, Current Step 4 Version.” November 2005. https://database.ich.org/sites/default/files/Q9%20Guideline.pdf

Generally, the four stages of business continuity planning will proceed in the order shown in Figure 1; however, as patient needs develop or business or regulatory landscapes change, it may be appropriate to make targeted adjustments within any one of the four stages to ensure the best outcomes.

In each of the four stages, a strong partnership between functional areas within a company will be required for success. The functional areas typically involved in these activities are as follows:

• Customer relations
• External business partnerships
• Manufacturing
• Medical affairs
• Procurement
• Regulatory affairs
• Sales and marketing
• Supply chain
• Technical/manufacturing operations

Because many issues and decisions related to business continuity planning will be best addressed after input is considered from multiple functional areas, it is equally important to formally designate a business continuity planning team leader who will have the authority to exercise decisions on behalf of all. Figure 2 illustrates the key stages and decision points for business planning discussed in this article.

Establishing Product Priority

A foundational activity for business continuity planning is determining the priority of products. Not all products merit the same level of business continuity planning because the impact of supply disruptions is not equal for all products. Considering product priority becomes even more important when the resources required to develop business continuity plans may be constrained. The relative priority of each product will be more reliable if it has been determined by evaluating products individually, as well as across the portfolio of products for which the company is the marketing authorization holder (MAH). This is because there may be important connections between products, often business related, which can influence the priority of an individual product.

Three perspectives primarily drive prioritization of products: therapeutic importance, regulatory requirements, and business significance. Because of the numerous perspectives that must be considered within these three areas when establishing the product priority, the evaluation of priority is best completed as a cross-functional activity and experts in the business areas listed previously should be consulted.

Therapeutic Importance

The medical significance of a product for patients is the most significant consideration when determining that product’s overall priority. There are several ways to differentiate the therapeutic importance of a product (Figure 3). Applying one therapeutic assessment globally is usually not sufficient because a product may have different therapeutic value across various markets. Additionally, within or across markets, each dosage form and strength within a product family may not always have the same medical priority. Sometimes, a specific dosage form and strength is developed to provide convenience to the health provider or patient and, as a result, its unavailability may not be as impactful as shortages of other dosage forms and strengths.

Regulatory Requirements

Health authorities (also known as national competent authorities) and health organizations, such as the World Health Organization (WHO), can influence product priority significantly through their definitions of what products may be critical, essential, or life-saving for patients in certain markets. They may also designate medically significant products through a set of criteria or through a list of products. For example, the WHO has long maintained an Essential Medicines List. 6 Additionally, governments may establish incentives to prioritize products manufactured in a certain market. Typically, health authorities have higher expectations for risk management and business continuity planning for products deemed to be more significant in their market(s).

Currently, there is no harmonized definition across markets regarding what products are significant to the patients. 7 , 8 As a result, it is imperative that pharmaceutical companies have insight into the definitions or lists applicable for the markets where their products are sold, and which products may be assigned to a national stockpile. Notably, the priority may be dynamic in a market. For example, in a large-scale event, a product that is valuable for emergency use could rapidly become essential and in high demand.

In addition to considering all regulations and governmental expectations when assessing the priority of a product in each market, it is important for companies to maintain constructive interactions with health authorities. 9  This will ensure that a company is able to develop a strategic approach to meet requirements across all markets and be poised to engage with the health authorities prior to or at the outset of any significant supply disruption or emergency. Early communication on drug supply challenges, preferably before supply disruptions occur, will maximize the assistance the health authorities may be able to provide to mitigate or prevent a drug shortage.

Business Significance

Business significance of a product should be assessed both from the perspective of the overall revenue position for the company as well as the market share of the product. If a product is essential for a company’s revenues, there may be no financial tolerance to have product supply unavailable for even a day. On the other end of the spectrum, a product might be sold in very low volume and manufactured only once or twice per year. Beyond failure-to-supply costs, which may be written into supply agreements, a supply gap for a low-volume product may have minimal patient impact or business significance. However, even an absence of a small-volume product can create significant challenges for patients who may rely on it, which could then generate business challenge for a company if the health care provider or patient reaction to the absence of product generates unfavorable publicity and impacts the overall reputation of the company.

A market share analysis is an important activity to complete when determining business significance. It should include an analysis of how much market share the company holds for the product, as well as how interconnected the competing suppliers may be to the manufacturing nodes. Generally, if the market for a specific product is divided across at least three manufacturers, 10 a supply disruption from one manufacturer may not make a significant difference to the overall market. However, if the market share is divided unevenly and the manufacturer experiencing the supply disruption contributes significantly to the overall industry-wide inventory, the disruption may drive an industry-wide shortage and competitors may have insufficient capacity to increase manufacturing to address the supply gap. Additionally, a product may be a higher priority if any risks to supply would likely impact multiple suppliers (e.g., all companies use the same raw material supplier), and very quickly create an industry-wide gap.

Lastly, connections between products, either within the portfolio of one company (i.e., one MAH holder) or connections with a partner company, may need to be considered when establishing the business significance for each product. One product may be interdependent with other products due to marketing, regulatory quality, or manufacturing supply requirements or strategies. Depending on the nature of the connection, a product that may otherwise be of lower priority may become more significant because interruption in its supply may impact other products the company markets or the company’s partnerships with other companies.

Setting Business Continuity Planning Target Levels

As noted earlier, the appropriate level of business continuity planning will vary by product. For the purposes of establishing a target level of business continuity planning, all of the perspectives described previously will contribute to the final priority categorization. Low-priority products do not typically merit rigorous business continuity planning activities, but the activities may be completed on a discretionary basis based on the company’s goals or preferences. For products that have priority from any of the three perspectives of therapeutic importance, regulatory requirements, or business significance, companies will need to apply an appropriate level of rigor to the business continuity planning activities, based on the perspectives driving the priority (Figure 4).

• 6 World Health Organization. “WHO Model Lists of Essential Medicines.” 2020. https://www.who.int/medicines/publications/essentialmedicines/en
• 7 ISPE Drug Shortages Initiative Core Team. “ISPE Offers Platforms to Progress Continuity of Supply of ‘Essential’ Medicines.” 11 September 2020. https://ispe.org/pharmaceutical-engineering/ispeak/ispe-offers-platforms-progress-continuity-supply-essential
• 8 Persaud, N., M. Jiang, R. Shaikh, et al. “Comparison of Essential Medicines Lists in 137 Countries.” Bulletin of the World Health Organization 97 (2019):394––404C. doi:10.2471/BLT.18.222448
• 9 Tomeo, D., K. Hirshfield, and D. L. Hustead. “Engage with Health Authorities to Mitigate & Prevent Drug Shortages.” Pharmaceutical Engineering 40, no. 4 (2020): 36–41. https://ispe.org/pharmaceutical-engineering/july-august-2020/engage-health-authorities-mitigate-prevent-drug
• 10 World Health Organization. “Medicines Shortages.” WHO Drug Information 20, no. 2 (2016): 180–185. https://www.who.int/medicines/publications/druginformation/WHO_DI_30-2_Medicines.pdf?ua=1

Assessing Risk to Supply

Once the product priority is established for a product, the company can assess the risks to supply with a better gauge for the potential level of impact of any identified risks. The key learnings from establishing product priority should be considered during the risk assessment process.

Table 1 shows typical areas to consider during a risk assessment for the purposes of preventing shortages. The areas listed are not exhaustive and may not be applicable to every product or company. Each company will need to determine what may best be included in their assessment and should address any company-specific issues or perspectives. Risk assessment activities may not need to be as comprehensive for low-priority products, particularly when any correlating supply disruption may have minimal patient impact.

The assessment of areas of potential risk should address the fundamental questions posed in ICH Q9: 5

• What might go wrong?
• What is the probability it will go wrong?
• What are the consequences?

An informal survey of ISPE membership has indicated that companies use a wide range of off-the-shelf and custom-designed risk assessment procedures, tools, and technology. ICH Q9 Annex I provides an overview of common tools for identifying what might go wrong and what is the probability it will go wrong. Table 2 1 , 5 , 9 – 17 lists other valuable guidance resources available to assist with the assessment of risk in pharmaceutical manufacturing.

*At the time of publication of this article, a new guidance from the FDA regarding risk management plans to mitigate potential for drug shortages was anticipated, but not yet available.

Risk assessments generally evaluate risks to (a) the product, (b) business systems, and (c) operations, and assessments of these three areas may be completed either individually or as a combination activity. When business continuity planning is done for only one area (products, business systems, or operations), the preventive measures may fall woefully short because product supply, business systems, and operations can all be disrupted simultaneously, such as in large-scale events (e.g., hurricanes, earthquakes, pandemics).

Beyond evaluating manufacturing reliability and quality maturity, business continuity planning to avoid drug shortages may benefit from integration with any governance, risk management, and compliance (GRC) or enterprise risk management (ERM) activities already in place for the company. For example, regarding risk to operations, the transformative nature of the COVID-19 pandemic may increase the importance of completing financial viability assessments of business partners, with consideration paid to not only primary business partners but also secondary and tertiary business partners. If a company does not have a formal GRC or ERM program, industry experts and software are available provide guidance suited to the needs of the organization. 18 , 19 , 20

Mitigation Options

The outcome of assessing risk to supply should be a road map of the key risks for the products, business systems, and operations to drive the selection of an appropriate business continuity approach.

A robust response plan should include both traditional mitigation options, such as redundancy of operations or increased inventory for safety stock, and agility strategy. Agility, as defined herein, is applied in the absence of an immediate back-up facility or inventory stockpile and should enable quick operational reactions to ensure resiliency for continued supply. It requires advanced, forward thinking and preparation to be successful. A well-designed agility strategy can be equally successful as redundancy; however, because agility strategy is by nature infrequently practiced, if it all, there may be some unexpected variation in the outcomes when activated. An appropriate blend of redundancy and agility will typically provide the best resiliency for continued supply. Figure 5 provides insight into the key considerations when selecting the best target on the business continuity planning options spectrum.

• 17 a b International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. “ICH Harmonised Tripartite Guideline: Pharmaceutical Quality System Q10, Current Step 4 Version.” 4 June 2008. https://database.ich.org/sites/default/files/Q10%20Guideline.pdf
• 11 US Food and Drug Administration. “Drug Shortages: Root Causes and Potential Solutions.” Updated 21 February 2020. https://www.fda.gov/media/131130/download
• 12 European Medicines Agency. “Guidance on Detection and Notification of Shortages of Medicinal Products for Marketing Authorisation Holders (MAHs) in the Union (EEA).” July 2019. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/guidance-detection-notification-shortages-medicinal-products-marketing-authorisation-holders-mahs_en.pdf
• 13 International Organization for Standardization. “ISO 14971:2019 Medical Devices—Application of Risk Management To Medical Devices.” December 2019. https://www.iso.org/standard/72704.html
• 14 World Health Organization. “Technical Consultation on Preventing and Managing Global Stock Outs of Medicines.” 8–9 December 2015. https://www.who.int/medicines/areas/access/Medicines_Shortages.pdf?ua=1
• 15 International Society for Pharmaceutical Engineering. “ISPE Drug Shortage Assessment and Prevention Tool.” 2015. https://ispe.org/sites/default/files/initiatives/drug-shortages/drug-shortage-assessment-tool-watermarked-307240.pdf
• 16 Parenteral Drug Association. Risk-Based Approach for Prevention and Management of Drug Shortages. PDA Technical Report no. 68. Bethesda, MD: Parenteral Drug Association, 2014.
• 18 Consultancy.org. “Global Risk Consulting Market Nears $70 Billion, Top 30 Consultancy Firms.” 13 December 2018. https://www.consultancy.org/news/101/global-risk-consulting-market-nears-70-billion-top-30-consultancy-firms
• 19 Gartner Peer Insights. “Integrated Risk Management (IRM) Solutions.” Accessed 26 December 2020. https://www.gartner.com/reviews/market/integrated-risk-management
• 20 G2. “Best GRC Platforms.” 12 August 2020. https://www.g2.com/categories/grc-platforms

Securing backup facilities or materials for pharmaceutical production or stockpiling inventory are longstanding redundancy options to ensure product supply. Although redundancy is well defined and generates expected results, it is costly due to necessary operational overhead. Unexpected complexity may also develop when a company maintains additional facilities, sources of supply, or inventory. Additionally, an adequate number of trained staff and practice runs for back-up operations are necessary to ensure a successful and timely transition to the redundant option, when needed. In some cases, limitations on the number of suppliers or raw material sources mean that redundant facilities or sources of supply are very difficult or impossible to achieve.

Given the implementation challenges or significant investment required to achieve redundancy or stockpiling, they are not always the best options for the manufacturing of every product or every step of manufacture of an individual product. For example, redundancy or stockpiling may not be appropriate for products that are deemed low priority for business continuity planning or products that involve few supply chain risks. Quite often, the decision for the best approach will require input from the various business areas listed earlier (customer relations, external business partnerships, legal, manufacturing, and so on). Because options analysis can quickly become complex, tools such as a decision-matrix method (e.g., Pugh matrix) 21 , 22 may help to guide selection of the best business continuity planning approach.

An important financial perspective to consider for business continuity plan decisions is that, as a general rule, it is better to decrease the level of bound capital along the supply chain from raw materials to API to bulk to the finished goods level because this may decrease the financial impact of the business continuity plan. Increasing inventory of raw materials, API, etc., at the earlier nodes of the supply chain will typically ensure lower, more efficient levels of finished product inventory. It is usually most cost-effective to have a second source for raw materials, excipients, and APIs and only stockpile the finished goods to the level required to meet the marketed forecast. Idle capacity cost should also be considered in the overall investment calculation during the establishment of a contingency plan.

Once redundancy and stockpiling decisions are made, operational agility will need to be developed to offset remaining risk for holistic business continuity planning. Agility requires a company to establish practices and processes to ensure they can address issues when they have occurred. Excelling in agility will allow a manufacturer to quickly pivot operations to maintain supply, such as increasing production or using alternative operations or materials to maintain product supply. Six Sigma 23 methodology may be helpful in evaluating and establishing appropriate agility approaches.

Key areas for agility strategy are supply chain, quality, strategic processes, business relationships, technology, regulatory, and metrics. The following are examples of how agility may be achieved in these areas.

• Advance thinking about potentially appropriate alternate suppliers (e.g., for raw materials, API, or finished product) can give a company a head start when faced with how to rapidly work with an alternate supplier that is not registered. Robust due diligence activities and well-maintained vendor qualification programs and supplier arrangements are recommended, as they may provide invaluable insights about timely and viable options amid an unexpected supply interruption.
• Companies that can quickly and completely understand the interconnectedness of a product and operations with other products and end markets have superior strategic options to redirect inventory to address market-specific supply disruptions.
• Diversification of suppliers may ensure continuous supply. There are signs that a shifting manufacturing footprint may be on the horizon, particularly due to the impact of COVID-19 on the pharma industry. 24 , 25
• Quality failures are the root cause for a significant number of drug shortages; 11 , 26  therefore, it is particularly important to ensure a robust pharmaceutical quality system (PQS) 17  across the life cycle of a product.
• A mature PQS—particularly in the areas of change management, monitoring, nonconformance investigations, corrective and preventive actions, complaint handling, and knowledge management—should identify early any issues that may impact continuous pharmaceutical supply, and this allows companies to implement appropriate and timely corrective actions to either mitigate or prevent a drug shortage.
• Lessons learned from regulatory inspections should provide opportunities for continual quality improvement.
• When developing manufacturing operations, it may be advantageous to group products with similar excipients to facilitate quick manufacturing switch outs. Having the ability to quickly ramp up one set of products and ramp down others could help companies mitigate a potential shortage situation.
• Challenging the system or operational practices periodically, based on lessons learned or other company experiences, can proactively identify new risks.
• Developing strong relationships with suppliers and contract manufacturing organizations (CMOs) to understand issues early is invaluable in ensuring the best outcomes for potential or actual supply disruptions.
• Having the ability to quickly start manufacture of a product at a CMO through contracts, foundational qualification work, and training (often referred to as a warm start 26 ) is an agile version of redundancy.
• Companies may want to establish relationships with competitors, so they may partner during significant supply disruptions to temporarily provide patients with an alternate source of supply.
• It can be challenging to use new technologies (e.g., continuous manufacturing) or an alternate type of existing technology (as described in scale-up and post-approval changes [SUPAC] guidance 27 , 28 , 29 , 30 , 31 for existing products. However, completing foundational development work for new or alternate technology before shortage event occurs may give a company a shorter runway for restart and may help the company adjust to increased demand.
• A well-planned regulatory strategy for registration dossiers may be a powerful way to mitigate or prevent drug shortages. As an example, ICH Q12 (Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management) 32  describes post-approval change management protocols (PACMPs) for registrations that may potentially alleviate post-approval change requirements. With the appropriate level of process and product understanding, PACMPs may be instrumental in ensuring continuous supply. Therefore, investing in upfront development and regulatory work for agility purposes can be foundational to success.
• Well-developed practices and procedures for engaging health authorities in advance of supply disruptions may help companies mitigate or prevent drug shortages because with early enough insight into an event that may disrupt drug supply, regulators may be able to provide pivotal assistance to help the company address the issue.
• Metrics to assess agility may or may not be needed and should be established as appropriate on a case--by-case basis. That said, traditional metrics are very valuable and will often help companies know when agility strategy may need to be employed. Traditional metrics closely linked to drug shortage identification and prevention are quality measures and demand forecasting. See the ISPE Drug Shortage Prevention Plan 1 for a more in-depth discussion of important metrics.
• Companies may want to establish a target timeline for transitioning to alternate supply options defined in business continuity plans. This may help companies better understand the overall impact of such transitions and whether predefined mitigation will be sufficient to address a supply disruption event.

Implementing, Monitoring, and Refreshing Response Plans

After the mitigation options and agility strategy are determined, the business continuity plan should be summarized and communicated across the company. Communication tools should include risk control documentation. Additionally, there may be a need to prioritize the implementation of the business continuity plans if multiple plans are established simultaneously.

The completion of the business continuity plan and communication of it are certainly noteworthy milestones to celebrate, but they are not the last steps. As noted earlier, circumstances for product supply may change over time, and these changes may impact the outcome of any of the business continuity activities described in the plans. As a result, planning is not a one-time project. However, companies with larger portfolios of products or limited staff may find it unsustainable to routinely reevaluate product priority, supply risks, and the resulting product response plan for each product. Therefore, it is essential to establish a process for a periodic review of changes in circumstances that may impact the risk outlook for supply of one or more products and merit a change to the established response plan. Though this process may vary by company, it is important to develop an event-based trigger to prompt interim reviews. Some key triggers are presented in Figure 6.

• 21 American Society of Quality. “Quality Resources: Decision Matrix.” Accessed 26 December 2020. https://asq.org/quality-resources/decision-matrix
• 22 Bouza-Rodríguez, J. B., A. Comesaña-Campos, and A. Menéndez-Díaz. “A Graphical Method to Assist Quality Decisions Throughout the Product Development Process.” Quality Engineering 26, no. 4 (2014): 467–478. https://asq.org/quality-resources/articles/a-graphical-method-to-assist-quality-decisions-throughout-the-product-development-process?id=8a0f57c336cb484b9784d9b948e4f412
• 23 Shanley, A. “Reinventing Lean Six Sigma for the Pharmaceutical Industry.” Pharmaceutical Technology 41, no. 10 (2017). https://www.pharmtech.com/view/reinventing-lean-six-sigma-pharmaceutical-industry
• 24 PwC. “Beyond China: US Manufacturers Are Sizing Up New and Cost-Efficient Global Footprints.” July 2020. https://www.pwc.com/us/en/library/fit-for-growth/assets/ffg-industrial-supply-chain-footprint.pdf
• 25 Steinberg, G. “COVID-19: How to Forge a Supply Chain that Withstands Severe Shocks.” Ernst & Young Global Limited. 27 November 2020. https://www.ey.com/en_us/consulting/how-to-forge-a-supply-chain-that-withstands-severe-shocks
• 26 a b Pew Charitable Trusts and the International Society for Pharmaceutical Engineering. “Drug Shortages An Exploration of the Relationship between U.S. Market Forces and Sterile Injectable Pharmaceutical Products: Interviews with 10 Pharmaceutical Companies.” January 2017. https://www.pewtrusts.org/-/media/assets/2017/01/drug_shortages.pdf
• 27 U.S. Food and Drug Administration. “Guidance for Industry: Immediate Release Solid Oral Dosage Forms; Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation.” November 1995. https://www.fda.gov/media/70949/download
• 28 U.S. Food and Drug Administration. “Guidance Document: SUPAC-IR: Questions and Answers about SUPAC-IR Guidance.” February 1997. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/supac-ir-questions-and-answers-about-supac-ir-guidance
• 29 U.S. Food and Drug Administration. “Guidance for Industry: Nonsterile Semisolid Dosage Forms; Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Release Testing and In Vivo Bioequivalence Documentation.” May 1997. https://www.fda.gov/media/71141/download
• 30 U.S. Food and Drug Administration. “Guidance for Industry: SUPAC-MR: Modified Release Solid Oral Dosage Forms; Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation.” September 1997. https://www.fda.gov/media/70956/download
• 31 U.S. Food and Drug Administration. “SUPAC: Manufacturing Equipment Addendum: Guidance for Industry.” December 2014. https://www.fda.gov/media/85681/download
• 32 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. “ICH Harmonised Tripartite Guideline: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management Q12: Final Version.” 20 November 2019. https://database.ich.org/sites/default/files/Q12_Guideline_Step4_2019_1119.pdf

Because changes in circumstances may occur in many areas of the business, convening a multifunctional business continuity task force for periodic reviews of potential changes may provide the best opportunity to identify where modifications to a response plan may be warranted. The functional areas listed earlier in the article should be considered when assigning team members to a business continuity task force.

It is important to select key metrics such as demand forecast, supply metrics, capacity, and inspection results that can provide early warnings of potential issues, and develop a plan for how the business continuity task force will monitor these metrics. Additionally, insight into key changes for each area will be needed. Processes should be established in each of the functional areas for how to escalate changes that may have significance to the business continuity plans and are therefore important for the task force to review. The processes should leverage existing systems, such as the quality change control process, for maximum efficiency and effectiveness.

After the periodic analysis is complete, a plan for refreshing impacted response plans should be developed. Additionally, the status of implementation of all business continuity plans and related updates should be monitored by the business continuity task force.

Lastly, and very importantly, any use of established business continuity plans to address an unexpected supply disruption will present an opportunity for evaluating how well the plans worked and if any adjustments should be made. In the absence of actual events, the business continuity plans may also be challenged with announced or unannounced practice runs. The business continuity task force should lead efforts to execute or challenge the business continuity plans and to evaluate the resulting lessons learned.

Health Authority Communications

Health authority interactions and communications are an identified component in the quality risk management process in ICH Q9 and may occur at any point during the different stages of business continuity planning or execution. With respect to ensuring continuity of drug supply, it is important to recognize that regulations are in place to ensure the safety, efficacy, and quality of pharmaceutical products. However, it may be riskier for patients to go without a drug, due to supply disruptions, than to use a drug that does not meet all regulatory provisions. Sometimes, the issue driving the supply disruption will have little or no bearing on the safety, efficacy, or quality of the product, or the issue may be addressed in an innovative way that is not covered by the registered application. Therefore, it is important that MAHs consider all options to achieve responsible regulatory compliance that keeps the benefit/risk profile of the patient at the forefront, and interact candidly with health authorities to determine the most appropriate path forward during challenging circumstances.

This article summarizes key stages and decision points for successful business continuity planning to mitigate and prevent drug shortages, and the foundational concepts described are aligned with ICH Q9 guideline, Quality Risk Management. 5 The approach was developed from across company experiences and has benefited from preliminary learnings from the COVID-19 pandemic. It will be reviewed and updated, if required, based on further learnings emerging from industry interactions and regulatory feedback.

Each drug shortage event presents unique challenges and opportunities for improvement, and the events related to COVID-19 are no exception. One of the many outcomes of the COVID-19 pandemic has been that companies have needed to rely on business continuity planning to be more flexible and sharpen their focus on ways to ensure continuous supply of critical medicines. When we overcome these difficult times, it will be important to understand which business continuity measures worked well during this enormous, global event and which did not. There will also be an important opportunity to identify which manufacturing or business practices developed during the pandemic may be appropriate to implement routinely for greater effectiveness in the supply chain overall. Exciting new directions and enduring solutions for preventing and mitigating drug shortages may be achieved, and this constant evolution in the business continuity planning space should always be embraced.

The ISPE Drug Shortages Team is a team of multidisciplinary experts who seek to assist ISPE membership, industry, and regulatory collaborations to reduce drug shortages globally through technology, quality, and manufacturing innovation and regulatory compliance. This team is actively monitoring developments related to drug shortages and is available to respond to any associated questions. We welcome input on best practices to support the continuity of supply and decision-making regarding actual or potential drug shortages.

Larger versions of the figures in this article are available here: Business Continuity Planning to Prevent Drug Shortages figures

Acknowledgment

The ISPE Drug Shortage Initiative Team collectively developed the content for this article and special recognition is extended to the following contributors:

James Canterbury, Principal, Ernst & Young LLP, Iselin, NJ

Dawn Culp, BS, Hikma Pharmaceuticals USA, Inc., Berkeley Heights, NJ

Nasir Egal, PhD, Sanofi, Washington, DC

Erin R. Fox, PharmD, University of Utah Health, Salt Lake City, UT

Jean Francois Duliere, Pharmaceutical Senior Expert and Consultant, Paris, France

Emma Harrington, Moderna, Norwood, MA,

Drishya Nair, MS, Ernst & Young US LLP, Iselin, NJ

Terrance Ocheltree, PhD, RPh, Corium, Inc., Libertyville, IL

Christopher J. Potter, CMC Pharmaceutical Consultant, Marlborough, UK

Thomas Zimmer, PhD, ISPE Vice President, European Operations , Harxheim, GER

• 'Share on Twitter'

About the Author

Related Articles

Innovation is an integral part of corporate strategy. Initiatives to facilitate innovation are continually developed and pursued. The 2022 ISPE Pharma 4.0™ Emerging Leader (EL) Hackathon was designed based on innovator needs and provided a hands-on blueprint manufacturing exercise. Over a period of two days and facilitated by 40 subject matter experts, coaches, and jury members, 50...

Advanced therapy medicinal products (ATMPs) are one of the most promising developments in the pharmaceutical and biotech industries in recent decades. Although there is a great promise to treat and even cure many diseases with these products, there are also unique challenges, especially with their supply chains.

The global supply network that underpins life science manufacturing is vast and highly complex. Maintaining a reliable inflow of critical materials depends on more than your relationship with a particular supplier—it also depends on that supplier’s supply chain, with further dependencies and variabilities all along the value chain. With contract manufacturers also in the mix, the complexity...

Drug distributor Cardinal Health to lose OptumRx contracts

• Medium Text

• Company Optumrx, Inc. Follow
• Company Cardinal Health Inc Follow
• Company Mckesson Corp Follow

Sign up here.

Reporting by Mariam Sunny in Bengaluru; Editing by Krishna Chandra Eluri and Shinjini Ganguli

Our Standards: The Thomson Reuters Trust Principles. New Tab , opens new tab

Business Chevron

LATAM scraps plan to acquire Boeing B737s after talks end with bankrupt Gol

LATAM Airlines said on Wednesday that it was no longer seeking to acquire Boeing B737 planes either from bankrupt Brazilian carrier Gol or other sources, opting to look for alternative narrowbody aircraft after talks failed.

Cardinal Health Falls as Optum Rx Distribution Contract Ends (1)

By John Tozzi

Cardinal Health Inc. shares fell the most in more than two months after the drug distributor lost a big contract with UnitedHealth Group Inc. ’s pharmacy benefits subsidiary.

The drug distribution contract with Optum Rx expires in June and won’t be renewed, Cardinal said Monday in a statement . Cardinal affirmed its fiscal 2024 adjusted earnings forecast of $7.20 to $7.35 a share.

Cardinal fell as much as 5.2% in New York trading Monday, the biggest intraday loss since Feb. 1.

The Optum contract, primarily bulk shipments to supply Optum’s mail-order pharmacy, accounted for 16% of Cardinal’s revenue for fiscal ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn about bloomberg law.

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.

Drug Rehabilitation Business Plan Template

Written by Dave Lavinsky

Drug Rehabilitation Business Plan

Over the past 20+ years, we have helped over 1,000 entrepreneurs and business owners create business plans to start and grow their drug rehabilitation companies. We have the experience, resources, and knowledge to help you create a great business plan.

In this article, you will learn some background information on why business planning is important. Then, you will learn how to write a drug rehabilitation business plan step-by-step so you can create your plan today.

Download our Ultimate Business Plan Template here >

What is a Drug Rehabilitation Business Plan?

A business plan provides a snapshot of your drug rehabilitation business as it stands today, and lays out your growth plan for the next five years. It explains your business goals and your strategies for reaching them. It also includes market research to support your plans.

Why You Need a Business Plan for a Drug Rehab Center

If you’re looking to start a drug rehabilitation business or grow your existing drug rehabilitation company, you need a business plan. A business plan will help you raise funding, if needed, and plan out the growth of your drug rehabilitation business to improve your chances of success. Your drug rehabilitation business plan is a living document that should be updated annually as your company grows and changes.

Sources of Funding for Drug Rehabilitation Businesses

With regards to funding, the main sources of funding for a drug rehabilitation business are personal savings, credit cards, bank loans, and angel investors. When it comes to bank loans, banks will want to review your business plan and gain confidence that you will be able to repay your loan and interest. To acquire this confidence, the loan officer will not only want to ensure that your financials are reasonable, but they will also want to see a professional plan. Such a plan will give them the confidence that you can successfully and professionally operate a business. Personal savings and bank loans are the most common funding paths for drug rehabilitation companies.

Finish Your Business Plan Today!

How to write a business plan for a drug rehabilitation business.

If you want to start a drug rehabilitation business or expand your current one, you need a business plan. The business plan outline below details the necessary information for how to write each essential component of your drug rehabilitation business plan.

Executive Summary

Your executive summary provides an introduction to your business plan, but it is normally the last section you write because it provides a summary of each key section of your plan.

The goal of your executive summary is to quickly engage the reader. Explain to them the kind of drug rehabilitation business you are running and the status. For example, are you a startup, do you have a drug rehabilitation business that you would like to grow, or are you operating a chain of drug rehabilitation businesses?

Next, provide an overview of each of the subsequent sections of your plan.

• Give a brief overview of the drug rehabilitation industry.
• Discuss the type of drug rehabilitation business you are operating.
• Detail your direct competitors. Give an overview of your target customers.
• Provide a snapshot of your marketing strategy. Identify the key members of your team.
• Offer an overview of your financial plan.

Company Overview

In your company overview, you will detail the type of drug rehabilitation business you are operating.

For example, you might specialize in one of the following types of drug rehabilitation businesses:

• Medical detox/symptom management drug rehabilitation: this type of drug rehabilitation focuses on medical assistance while individuals are in withdrawal, along with the management of symptoms the individual may have during recovery.
• Substance abuse treatment center: Commonly seen as highly-effective, substance abuse treatment centers focus on one or a combination of the following: counseling, group therapy, medically-assisted treatment therapy (MAT) and other forms of assistance that support holistic health and well-being.
• Self-help drug rehabilitation: this type of therapy is designed for someone who prefers to work on an individual basis with one counselor, commonly a professional certified in alcohol and drug rehabilitation.

In addition to explaining the type of drug rehabilitation business you will operate, the company overview needs to provide background on the business.

Include answers to questions such as:

• When and why did you start the business?
• What milestones have you achieved to date? Milestones could include the number of patients served, the number of cases with positive outcomes, reaching X number of contracted medical providers who refer directly to your company, etc.
• Your legal business Are you incorporated as an S-Corp? An LLC? A sole proprietorship? Explain your legal structure here.

Industry Analysis

In your industry or market analysis, you need to provide an overview of the drug rehabilitation industry.

While this may seem unnecessary, it serves multiple purposes.

First, researching the drug rehabilitation industry educates you. It helps you understand the market in which you are operating.

Secondly, market research can improve your marketing strategy, particularly if your analysis identifies market trends.

The third reason is to prove to readers that you are an expert in your industry. By conducting the research and presenting it in your plan, you achieve just that.

The following questions should be answered in the industry analysis section of your drug rehabilitation business plan:

• How big is the drug rehabilitation industry (in dollars)?
• Is the market declining or increasing?
• Who are the key competitors in the market?
• Who are the key suppliers in the market?
• What trends are affecting the industry?
• What is the industry’s growth forecast over the next 5 – 10 years?
• What is the relevant market size? That is, how big is the potential target market for your drug rehabilitation business? You can extrapolate such a figure by assessing the size of the market in the entire country and then applying that figure to your local population.

Customer Analysis

The customer analysis section of your drug rehabilitation business plan must detail the customers you serve and/or expect to serve.

The following are examples of customer segments: individuals, family members of addicts, physicians and licensed therapists.

As you can imagine, the customer segment(s) you choose will have a great impact on the type of drug rehabilitation business you operate. Clearly, individuals would respond to different marketing promotions than medical personnel, for example.

Try to break out your target customers in terms of their demographic and psychographic profiles. With regards to demographics, including a discussion of the ages, genders, locations, and income levels of the potential customers you seek to serve.

Psychographic profiles explain the wants and needs of your target customers. The more you can recognize and define these needs, the better you will do in attracting and retaining your customers.

Finish Your Drug Rehabilitation Business Plan in 1 Day!

Don’t you wish there was a faster, easier way to finish your business plan?

With Growthink’s Ultimate Business Plan Template you can finish your plan in just 8 hours or less!

Competitive Analysis

Your competitive analysis should identify the indirect and direct competitors your business faces and then focus on the latter.

Direct competitors are other drug rehabilitation businesses.

Indirect competitors are other options that customers have to purchase from that aren’t directly competing with your product or service. This includes psychiatrists, other healthcare providers, or members of the clergy. You need to mention direct competition, as well.

For each direct competitor, provide an overview of their business and document their strengths and weaknesses. Unless you once worked at your competitors’ businesses, it will be impossible to know everything about them. But you should be able to find out key things about them such as

• What types of customers do they serve; in-patient or out-patient?
• What type of drug rehabilitation business are they?
• What is their pricing (premium, low, etc.)?
• What are they good at?
• What are their weaknesses?

With regards to the last two questions, think about your answers from the customers’ perspective. And don’t be afraid to ask your competitors’ customers what they like most and least about them.

The final part of your competitive analysis section is to document your areas of competitive advantage. For example:

• Will you provide options for the uninsured?
• Will you offer 24/7 care services that your competition doesn’t?
• Will you provide a one-to-one ratio of therapist- to-addict service?
• Will you provide certified personnel in every department of your business?

Think about ways you will outperform your competition and document them in this section of your plan.

Marketing Plan

Traditionally, a marketing plan includes the four P’s: Product, Price, Place, and Promotion. For a drug rehabilitation business plan, your marketing strategy should include the following:

Product : In the product section, you should reiterate the type of drug rehabilitation company that you documented in your company overview. Then, detail the specific products or services you will be offering. For example, will you provide therapy that includes in-patient care coupled with therapy sessions for management of addiction?

Price : Document the prices you will offer and how they compare to your competitors. Essentially in the product and price sub-sections of your plan, you are presenting the products and/or services you offer and their prices.

Place : Place refers to the site of your drug rehabilitation company. Document where your company is situated and mention how the site will impact your success. For example, is your drug rehabilitation business located near a hospital, in a clinic in a pleasant neighborhood, or is it in a stand-alone building? Discuss how your site might be the ideal location for your customers.

Promotions : The final part of your drug rehabilitation marketing plan is where you will document how you will drive potential customers to your location(s). The following are some promotional methods you might consider:

• Advertise in local papers, radio stations and/or magazines
• Reach out to websites
• Distribute flyers to area medical and therapist personnel
• Engage in email marketing
• Advertise on social media platforms
• Improve the SEO (search engine optimization) on your website for targeted keywords

Operations Plan

While the earlier sections of your business plan explained your goals, your operations plan describes how you will meet them. Your operations plan should have two distinct sections as follows.

Everyday short-term processes include all of the tasks involved in running your drug rehabilitation business, including answering calls, overseeing clinic or substance abuse treatment center practices, providing daily care, billing insurance, etc.

Long-term goals are the milestones you hope to achieve. These could include the dates when you expect to book your Xth substance abuse treatment center patient, or when you hope to reach $X in revenue. It could also be when you expect to expand your drug rehabilitation business to a new city.

Management Team

To demonstrate your drug rehabilitation business’ potential to succeed, a strong management team is essential. Highlight your key players’ backgrounds, emphasizing those skills and experiences that prove their ability to grow a company.

Ideally, you and/or your team members have direct experience in managing drug rehabilitation businesses. If so, highlight this experience and expertise. But also highlight any experience that you think will help your business succeed.

If your team is lacking, consider assembling an advisory board. An advisory board would include 2 to 8 individuals who would act as mentors to your business. They would help answer questions and provide strategic guidance. If needed, look for advisory board members with experience in managing a drug rehabilitation business or successfully running a therapist practice.

Financial Plan

Your financial plan should include your 5-year financial statement broken out both monthly or quarterly for the first year and then annually. Your financial statements include your income statement, balance sheet, and cash flow statements.

Income Statement

An income statement is more commonly called a Profit and Loss statement or P&L. It shows your revenue and then subtracts your costs to show whether you turned a profit or not.

In developing your income statement, you need to devise assumptions. For example, will you admit 10 new patients per day, and/or offer group therapy sessions? And will sales grow by 2% or 10% per year? As you can imagine, your choice of assumptions will greatly impact the financial forecasts for your business. As much as possible, conduct research to try to root your assumptions in reality.

Balance Sheets

Balance sheets show your assets and liabilities. While balance sheets can include much information, try to simplify them to the key items you need to know about. For instance, if you spend $50,000 on building out your drug rehabilitation business, this will not give you immediate profits. Rather it is an asset that will hopefully help you generate profits for years to come. Likewise, if a lender writes you a check for $50,000, you don’t need to pay it back immediately. Rather, that is a liability you will pay back over time.

Cash Flow Statement

Your cash flow statement will help determine how much money you need to start or grow your business, and ensure you never run out of money. What most entrepreneurs and business owners don’t realize is that you can turn a profit but run out of money and go bankrupt.

When creating your Income Statement and Balance Sheets be sure to include several of the key costs needed in starting or growing a drug rehabilitation business:

• Cost of equipment, furnishings, and housing
• Payroll or salaries paid to staff
• Business insurance
• Other start-up expenses (if you’re a new business) like legal expenses, permits, computer software, and equipment

Attach your full financial projections in the appendix of your plan along with any supporting documents that make your plan more compelling. For example, you might include your office location mortgage or a list of contracted providers who refer individuals to your substance abuse treatment center.

Writing a business plan for your drug rehabilitation business is a worthwhile endeavor. If you follow the template above, by the time you are done, you will truly be an expert. You will understand the drug rehabilitation industry, your competition, and your customers. You will develop a marketing strategy and will understand what it takes to launch and grow a successful drug rehabilitation business.

Drug Rehabilitation Business Plan FAQs

What is the easiest way to complete my drug rehabilitation business plan.

Growthink's Ultimate Business Plan Template allows you to quickly and easily write your drug rehabilitation business plan.

How Do You Start a Drug Rehabilitation Business?

Starting a Drug Rehabilitation business is easy with these 14 steps:

• Choose the Name for Your Drug Rehabilitation Business
• Create Your Drug Rehabilitation Business Plan
• Choose the Legal Structure for Your Drug Rehabilitation Business
• Secure Startup Funding for Your Drug Rehabilitation Business (If Needed)
• Secure a Location for Your Business
• Register Your Drug Rehabilitation Business with the IRS
• Open a Business Bank Account
• Get a Business Credit Card
• Get the Required Business Licenses and Permits
• Get Business Insurance for Your Drug Rehabilitation Business
• Buy or Lease the Right Drug Rehabilitation Business Equipment
• Develop Your Drug Rehabilitation Business Marketing Materials
• Purchase and Setup the Software Needed to Run Your Drug Rehabilitation Business
• Open for Business

Where Can I Download a Free Business Plan Template PDF?

Click here to download the pdf version of our basic business plan template.

Our free business plan template pdf allows you to see the key sections to complete in your plan and the key questions that each must answer. The business plan pdf will definitely get you started in the right direction.

We do offer a premium version of our business plan template. Click here to learn more about it. The premium version includes numerous features allowing you to quickly and easily create a professional business plan. Its most touted feature is its financial projections template which allows you to simply enter your estimated sales and growth rates, and it automatically calculates your complete five-year financial projections including income statements, balance sheets, and cash flow statements. Here’s the link to our Ultimate Business Plan Template.

Don’t you wish there was a faster, easier way to finish your Drug Rehabilitation business plan?

OR, Let Us Develop Your Plan For You

Since 1999, Growthink has developed business plans for thousands of companies who have gone on to achieve tremendous success.   Click here to learn about Growthink’s business plan writing services .

Other Helpful Business Plan Articles & Templates

We've detected unusual activity from your computer network

To continue, please click the box below to let us know you're not a robot.

Why did this happen?

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy .

For inquiries related to this message please contact our support team and provide the reference ID below.

• Share full article

Advertisement

Supported by

Tesla Seeks to Revive Musk’s $47 Billion Pay Deal After Judge Says No

The company’s directors are asking shareholders to again approve the multibillion-dollar compensation plan and to move the company’s registration to Texas, from Delaware.

By Jack Ewing

Facing criticism that it is overly beholden to Elon Musk, Tesla’s board of directors said on Wednesday that it would essentially give him everything he wanted, including the biggest pay package in corporate history.

If setbacks in court and the car market have induced any soul searching among Tesla’s board, there was no sign of it in the latest announcement. If anything, the board doubled down on backing Mr. Musk, Tesla’s chief executive, risking riling up activist investors and more litigation.

The board’s decision to ask shareholders to endorse a compensation plan for Mr. Musk that is worth about $47 billion came less than three months after a Delaware judge voided the same 10-year pay package. The judge said that it was excessive and that the company had failed to properly disclose details about it to shareholders who approved it in 2018.

Tesla will now provide shareholders more information about how the plan was devised and ask them to approve it again. That vote will take place as investors are increasingly worried about the electric car company because its sales are declining , and its stock has fallen more than one-third this year. In addition, Mr. Musk has not presented much of a plan to restore the company’s momentum.

Greg Varallo, a lawyer who represented shareholders in the Delaware case, declined to comment Wednesday on steps his team might take. But the board’s action is likely to prompt more lawsuits against the company, which is under legal pressure from regulators, customers and people who say they have been victims of faults in Tesla’s driver-assistance system .

Two days before the move to restore Mr. Musk’s status as one of the world’s richest people, Tesla told employees that it would lay off 10 percent of its work force, or about 14,000 people.

“The optics certainly don’t look good,” said Jason Schloetzer, an associate professor at Georgetown University’s McDonough School of Business who studies corporate governance.

There is no sign that Tesla’s board is trying to exert tighter control over Mr. Musk, whose endorsement of right-wing conspiracy theories has alienated many potential customers. On the contrary, in documents filed Wednesday for a shareholders meeting in June, the board signaled that it stood firmly behind Mr. Musk.

The board asked shareholders to approve moving Tesla’s corporate domicile to Texas from Delaware, a change Mr. Musk called for on the day the Delaware court struck down his pay package in January. And the board asked shareholders to reappoint two directors with close ties to Mr. Musk: the media executive James Murdoch, who has vacationed with Mr. Musk, and Kimbal Musk, his brother.

The company’s moves effectively amounted to a rebuke of the judge who struck down Mr. Musk’s 2018 pay plan, Chancellor Kathaleen St. J. McCormick of the Delaware Court of Chancery. In her ruling, the judge chided the board for lax oversight of Mr. Musk.

“The board and the shareholders were controlled by Musk,” Lynne Vincent, associate professor at Syracuse University’s Whitman School of Management, said of the court decision. “The people who were advocating for this deal were not active protectors of shareholder interests. They were embedded in his personal lives and financial lives.”

By asking shareholders to reinstate Mr. Musk’s compensation, Tesla’s board is trying to render Chancellor McCormick’s decision moot.

“We do not agree with what the Delaware Court decided, and we do not think that what the Delaware Court said is how corporate law should or does work,” Robyn Denholm, the chair of Tesla’s board, said in a message to shareholders Wednesday. The company has separately said it plans to appeal the judge’s decision.

Ms. Denholm said it would be “fundamentally unfair” to deny Mr. Musk compensation that he had been promised. She noted that Tesla had not paid Mr. Musk anything for the past six years besides the compensation plan that was struck down.

But Mr. Musk has earned billions from his Tesla shares. Brian Dunn, a former compensation consultant and visiting lecturer at Cornell University’s School of Industrial and Labor Relations, said pay plans were supposed to provide incentives for executives to perform in the future, not reward them for work in the past.

“There is nothing in the plan that requires him to focus on Tesla,” Mr. Dunn said, noting Mr. Musk’s ownership of X, the social media platform, and ventures like SpaceX. “It’s evidence of the board still being very complacent,” he added.

Some investors found the fairness argument jarring given Tesla’s recent troubles.

“Asking for people to approve one of the largest pay packages of all time, when the company is failing to meet current targets and terminating 10 percent of employees, it’s terrible timing,” said Antoine Argouges, chief executive of Tulipshare, an activist investor group.

Tulipshare has proposed a shareholder vote on whether executive compensation at Tesla should be contingent on meeting standards on carbon emissions and worker rights. Tesla’s board opposes the proposal.

Ms. Denholm framed the decision to leave Delaware as a logical step for a company with a growing presence in Texas, rather than an attempt to escape the state’s justice system. “We have a significant number of manufacturing, operations and engineering employees in Texas, and our executives are based there,” she told shareholders.

She insisted that the board is independent. The board member who assessed Mr. Musk’s compensation plan, Ms. Denholm said, was Kathleen Wilson-Thompson, a former human resources executive at Kellogg and Walgreens who does not appear to have any personal ties to him.

Tesla’s board members are listening to shareholders, the board said in a proxy statement filed on Wednesday. “The board maintains an active, year-round dialogue with our largest stockholders to ensure that Tesla’s board and management understand and consider the issues that matter most to our stockholders,” the statement said.

Ms. Denholm and the board did not respond to statements Mr. Musk made in January that if he wasn’t given control of over 25 percent of the company’s stock he would pursue certain ventures outside Tesla. He currently owns about 13 percent of Tesla’s shares, down from 22 percent after he sold billions of dollars of stock to finance the acquisition of Twitter, now known as X.

Ms. Vincent of Syracuse University said Tesla had offered little information on how decisions on layoffs and compensation were made. “I don’t think any of this has been transparent," she said.

Tesla’s board did not address concerns that the company was losing its grip on the market for electric cars. Ms. Denholm presented a rosy view of Tesla’s future.

“Tesla is a nimble organization with an unmatched pace of innovation that has resulted in products and services that surpass all expectations driven by visionary leadership and, most importantly, the best and most dedicated employees in the world,” she said in her message to shareholders.

The decision to fire 10 percent of those employees, she added, was needed to reduce costs, increase productivity and “prepare us for our next phase of growth.”

Jack Ewing writes about the auto industry with an emphasis on electric vehicles. More about Jack Ewing

The World of Elon Musk

The billionaire’s portfolio includes the world’s most valuable automaker, an innovative rocket company and plenty of drama..

A $47 Billion Pay Deal: Despite   facing criticism that Tesla is overly beholden to Elon Musk , its board of directors said that the company would essentially give him everything he wanted, including the biggest pay package in corporate history.

Tesla: Tesla reported that it made significantly less money  in the first three months of the year because of its tepid car sales, reinforcing concern among investors that the company led by Elon Musk is losing ground  in the market for electric vehicles.

SpaceX: President Biden wants companies that use American airspace for rocket launches to start paying taxes into a federal fund  that finances the work of air traffic controllers.

Business With China : Tesla and China built a symbiotic relationship that made Elon Musk ultrarich. Now, his reliance on the country may give Beijing leverage .  

The Musk Foundation: After making billions in tax-deductible donations to his charity, Musk has failed recently to donate the minimum required to justify a tax break  — and what he did give often supported his interests.

OpenAI: Musk, who helped found the A.I. start-up in 2015, has filed a lawsuit  accusing the company and its chief executive  of breaching a contract  by putting profits and commercial interests ahead of the public good.